Hazardous Substances (Veterinary Medicines) Transfer Notice 2005
Pursuant to section 160A of the Hazardous Substances and New Organisms Act 1996 (in this notice referred to as the Act), the Environmental Risk Management Authority gives the following notice.

Contents

1 Title2 Commencement3 Interpretation4 Deemed assessment and approval5 Deemed hazard classification6 Application of controls and changes to controls7 Other obligations and restrictions8 Workplace exposure standards

Schedule 1List of substances (veterinary medicines) to be transferredSchedule 2Changes to controls for veterinary medicines Schedule 3New controls for veterinary medicinesSchedule 4Transitional controls
______________________________

1 Title
This notice is the Hazardous Substances (Veterinary Medicines) Transfer Notice 2005.
2 Commencement
This notice comes into force on 1 July 2005.
3 Interpretation
(1) In this notice, words and phrases have the meanings given to them in the Act and in regulations made under the Act.
(2) In this notice, the following words and phrases have the following meanings:
annual retention certificate means a certificate issued by the Veterinary Council of New Zealand in accordance with section 6 of the Veterinarians Act 1994.
exportation means any shipment in any craft for transportation to a destination outside New Zealand.

export-only substance means:
(a) a hazardous substance listed in Table 1 of Schedule 1 where that substance is in a package, and that package is destined for exportation; or
(b) a hazardous substance listed in Table 2 of Schedule 1.
multiple package means a package consisting of two or more inner packages.
UN Model Regulations means the 13th revised edition of the Recommendation on the Transport of Dangerous Goods Model Regulations, published in 2003 by the United Nations.
variation code, in relation to a substance described in Schedule 1, means a number set out in the column entitled “variation code(s)” opposite the description of the substance in Schedule 1.
veterinary medicine has the meaning given to it in the Agricultural Compounds and Veterinary Medicines Act 1997.
veterinarian has the meaning given to it in the Veterinarians Act 1994.
4 Deemed assessment and approval
(1) On the commencement of this notice, the hazardous substances described in Schedule 1 (veterinary medicines) are no longer subject to the provisions of Parts XI to XV of the Act.
(2) Each hazardous substance described in Table 1 of Schedule 1 is deemed to have been assessed and approved by the Authority under section 29 of the Act for use as a veterinary medicine.
(3) Each hazardous substance described in Table 2 of Schedule 1 is deemed to have been assessed and approved by the Authority under section 29 of the Act for manufacture as a veterinary medicine.
5 Deemed hazard classification
Each hazardous substance described in Schedule 1 is deemed to have the hazard classifications specified opposite its description in Schedule 1.
6 Application of controls and changes to controls
(1) The controls that apply to the hazardous substances described in Schedule 1 are as follows:
(a) the Hazardous Substances (Classes 1 to 5 Controls) Regulations 2001, with the changes indicated in Schedule 2:
(b) the Hazardous Substances (Classes 6, 8, and 9 Controls) Regulations 2001, with the changes indicated in Schedule 2:
(c) the Hazardous Substances (Packaging) Regulations 2001, with the changes indicated in Schedule 2:
(d) the Hazardous Substances (Disposal) Regulations 2001, with the changes indicated in Schedule 2:
(e) the Hazardous Substances (Tracking) Regulations 2001, with the changes indicated in Schedule 2:
(f) the Hazardous Substances and New Organisms (Personnel Qualifications) Regulations 2001:
(g) the Hazardous Substances (Emergency Management) Regulations 2001, with the changes indicated in Schedule 2:
(h) the Hazardous Substances (Identification) Regulations 2001, with the changes indicated in Schedule 2:
(i) the Hazardous Substances (Compressed Gases) Regulations 2004:
(j) the Hazardous Substances (Tank Wagon and Transportable Containers) Regulations 2004:
(k) the controls for stationary container systems set out in Schedule 8 of the Hazardous Substances (Dangerous Goods and Scheduled Toxic Substances) Transfer Notice 2004 (Gazette, 2004, No 35, p 767), as amended by the Hazardous Substances (Dangerous Goods and Scheduled Toxic Substances) (Amendment) Transfer Notice 2004 (Gazette, 2004, No 128, p 3133), with the changes indicated in Schedule 2:
(l) the controls for the adverse effects of unintended ignition of class 2 and class 3.1 hazardous substances set out in Schedule 10 of the Hazardous Substances (Dangerous Goods and Scheduled Toxic Substances) Transfer Notice 2004 (Gazette, 2004, No 35 p 767), (as amended), with the changes indicated in Schedule 2.
(2) Subclause (1)(k) applies despite clause 1(1) of Schedule 8 of the Hazardous Substances (Dangerous Goods and Scheduled Toxic Substances) Transfer Notice 2004 (as amended).
(3) Subclause (1)(l) applies despite clause 1 of Schedule 10 of the Hazardous Substances (Dangerous Goods and Scheduled Toxic Substances) Transfer Notice 2004 (as amended).
7 Other obligations and restrictions
The obligations and restrictions specified in Schedule 3 (new controls for veterinary medicines) and Schedule 4 (transitional controls) are imposed as controls under section 160B of the Act applying to the hazardous substances described in Schedule 1.
8 Workplace exposure standards
(1) Under regulation 29(2) of the Hazardous Substance (Classes 6, 8, and 9 Controls) Regulations 2001, the Authority adopts as a workplace exposure standard in relation to each hazardous substance described in Schedule 1, and each component of each hazardous substance described in that Schedule, the value or values specified in the document described in subclause (2) relating to that hazardous substance, or component, if any.
(2) The document referred to in subclause (1) is the document entitled “Workplace Exposure Standards”, published by the Occupational Safety and Health Service, Department of Labour, January 2002, ISBN 0-477-03660-0.

Schedule 1
List of substances (veterinary medicines) to be transferred

Explanatory notes to list of substances (veterinary medicines) to be transferred: These notes are not part of the notice, but are intended to assist in understanding its scheme.

Substances listed in the following table are listed alphabetically by active. Substances containing a single active are listed first, followed by dual actives, triple actives, and so on.
Variation code 1 relates to a change to regulation 56 (class 2, 3, and 4 approved handler requirements) of the Hazardous Substances (Classes 1 to 5 Controls) Regulations 2001.
Variation code 2 relates to a change to regulation 81 (test certification requirements) of the Hazardous Substances (Classes 1 to 5 Controls) Regulations 2001.
Variation code 3 relates to a change to regulation 89 (class 5 approved handler requirements) of the Hazardous Substances (Classes 1 to 5 Controls) Regulations 2001.
Variation code 4 relates to a change to regulation 5 (requirement to keep record of application) of the Hazardous Substances (Classes 6, 8, and 9 Controls) Regulations 2001.
Variation code 5 relates to a change to regulation 7 (requirements for equipment used to handle substances) of the Hazardous Substances (Classes 6, 8, and 9 Controls) Regulations 2001
Variation code 6 relates to a change to regulation 8 (protective clothing and equipment) of the Hazardous Substances (Classes 6, 8, and 9 Controls) Regulations 2001.
Variation codes 7 to 9 relate to a change to regulation 9 (approved handler requirements) of the Hazardous Substances (Classes 6, 8, and 9 Controls) Regulations 2001.
Variation code 10 relates to a change to regulation 10 (carriage of hazardous substances on passenger service vehicles) of the Hazardous Substances (Classes 6, 8, and 9 Controls) Regulations 2001.
Variation code 11 relates to a change to regulation 11 (requirement to set an ADE or RfD) of the Hazardous Substances (Classes 6, 8, and 9 Controls) Regulations 2001.
Variation code 12 relates to a change to regulations 32 and 33 (environmental exposure limits) of the Hazardous Substances (Classes 6, 8, and 9 Controls) Regulations 2001.
Variation code 13 relates to a change to regulation 32 (environmental exposure limits) of the Hazardous Substances (Classes 6, 8, and 9 Controls) Regulations 2001.
Variation codes 14 to 16 relate to changes to regulation 19 (packaging requirements for toxic substances) of the Hazardous Substances (Packaging) Regulations 2001.
Variation code 17 relates to a change to regulations 4 to 6 (records and transfer of tracked substances) of the Hazardous Substances (Tracking) Regulations 2001.
Variation codes 18 to 21 relate to a change to regulation 8 (information requirements for ecotoxic substances) of the Hazardous Substances (Emergency Management) Regulations 2001.
Variation codes 18 to 21 also relate to a change to regulation 20 (secondary identifiers for ecotoxic substances) of the Hazardous Substances (Identification) Regulations 2001.
Variation codes 22 to 25 relate to a change to regulation 9 (priority identifiers for ecotoxic substances) of the Hazardous Substances (Identification) Regulations 2001.
Variation codes 26 to 30 relate to a change to regulation 14 (priority identifiers), regulation 25 (secondary identifiers) and regulation 46 (documentation requirements) of the Hazardous Substances (Identification) Regulations 2001.
Variation codes 31 to 33 relate to changes to regulation 25 (secondary identifiers for toxic substances) of the Hazardous Substances (Identification) Regulations 2001.
Variation code 34 relates to a change to regulation 52 (signage requirements) of the Hazardous Substances (Identification) Regulations 2001.


Table 1
Veterinary medicines that are for use in New Zealand

Substance Hazard classification(s) Variation code(s)
Liquid containing 1 – 3 g/litre 2-bromo-2-nitropropane-1,3-diol and 0.25 – 0.75 g/litre dichlorobenzyl alcohol 6.3A, 6.5B, 8.3A, 9.1D 10, 11, 12
Paste containing 1.5 – 2.5% 2-hydroxybenzoic acid, 1 – 1.3% camphor, 1 – 1.3% phenol, and 1.5 – 2.5% sulphur 6.3A, 6.4A, 6.5B, 6.6A, 6.8B, 6.9B, 9.1D 10, 11, 12
Liquid containing 1.4 – 2.6% 2-hydroxybenzoic acid, 0.7 – 1.3% carbaryl and 0.11 – 0.29% chlorocresol 6.1E, 6.3B, 6.4A, 6.5B, 6.7B, 6.9B, 9.1C, 9.4C 10, 13, 19, 23
Liquid containing 1.8 – 2.4% 2-hydroxybenzoic acid, 12 – 18% coal tar, 30 – 33% sodium lauryl sulphate and 1.8 – 2.4% sulphur 6.1D, 6.3B, 6.4A, 6.6A, 6.7A, 9.1D, 9.2D 4, 9, 11, 12
Liquid containing 9 – 13% 2-hydroxybenzoic acid, 4 – 6% iodine and 9 – 13% sulphathiazole 6.1E, 6.3A, 6.5B, 6.9B, 8.3A, 9.1B 10, 11, 12, 18, 22
Liquid containing 0.05 – 0.15% 2-hydroxybenzoic acid, 1.8 – 2.98% lactic acid and 32 – 40% propylene glycol 6.3A, 6.4A, 6.5B 10, 11
Liquid containing 9 – 16 g/litre 2-phenoxyethanol, 3 – 7 g/litre chloroxylenol, 7 – 13 g/litre econazole nitrate and 25 – 45 g/litre sodium salicylate 6.1E, 6.3A, 6.5B, 8.3A, 9.1C 10, 11, 12
Liquid containing 30 – 70 g/litre 2-propenoic acid, polymer with 2-propenal 6.5B 10, 11
Liquid containing 0.1 – 0.14% abamectin 6.5B, 6.8B, 6.8C, 9.1A, 9.2C, 9.4A 4, 7, 10, 13, 17
Liquid containing 0.3 – 0.4% abamectin 6.1E, 6.8B, 6.8C, 9.1A, 9.2C, 9.4A 4, 7, 13, 17
Liquid containing 0.4 – 0.9 g/litre abamectin 6.5B, 6.8B, 9.1A, 9.2C, 9.4A 4, 7, 10, 13, 17
Flammable liquid containing 10 – 15 g/litre abamectin 3.1D, 6.1D, 6.5B, 6.8B, 6.8C, 6.9B, 9.1A, 9.2C, 9.3C, 9.4A 4, 7, 10, 13, 17
Liquid containing 10 – 15 g/litre abamectin (Substance A) 6.1D, 6.4A, 6.5B, 6.8B, 6.8C, 6.9B, 9.1A, 9.2B, 9.3C, 9.4A 4, 7, 10, 13, 17
Liquid containing 10 – 15 g/litre abamectin (Substance B) 6.1D, 6.8B, 6.8C, 6.9B, 9.1A, 9.2C, 9.3C, 9.4A 4, 7, 13, 17
Liquid containing 10 – 15 g/litre abamectin (Substance C) 6.1D, 6.8B, 6.8C, 6.9B, 9.1A, 9.2C, 9.3C, 9.4A 4, 7, 13, 17
Paste containing 2.6 – 4.1 g/kg abamectin, 112 – 168 g/kg bithionol and 170 – 230 g/kg oxibendazole 6.1E, 6.3A, 6.4A, 6.5B, 6.8B, 6.8C, 9.1A, 9.2C, 9.4A 4, 7, 10, 13, 17
Liquid containing 1 g/litre abamectin and 35 – 50 g/litre closantel 6.1E, 6.4A, 6.5B, 6.8B, 6.8C, 6.9B, 9.1A, 9.2C, 9.4A 4, 7, 10, 13, 17
Liquid containing 1 – 1.3% abamectin and 16 – 24% levamisole 6.1D, 6.4A, 6.5B, 6.6B, 6.8B, 6.8C, 6.9A, 9.1A, 9.2C, 9.3B, 9.4A 4, 7, 10, 13, 17
Liquid containing 1 – 1.5 g/litre abamectin, 30 – 50 g/litre levamisole, 20 – 30 g/litre oxfendazole and 0.9 – 1.5 g/litre sodium selenate 6.1E, 6.5A, 6.5B, 6.6B, 6.7B, 6.8B, 6.8C, 6.9B, 9.1A, 9.4A 4, 7, 10, 13, 17
Solid containing 0.09 – 0.15 g/kg abamectin, 160 – 240 g/kg oxybendazole and 30 – 70 g/kg praziquantel 9.1B, 9.4B 13, 19, 23
Paste containing 0.2 – 0.37 g/litre abamectin and 30 – 50 g/litre praziquantel 6.1E, 6.8B, 6.8C, 9.1A, 9.2C, 9.4A 4, 7, 13, 17
Liquid containing 0.6 – 0.9 g/litre abamectin and 10 – 20 g/litre praziquantel 6.5B, 6.8B, 9.1A, 9.2C, 9.4A 4, 7, 10, 13, 17
Liquid containing 1 – 1.5 g/litre abamectin and 16 – 22 g/litre praziquantel 6.1E, 6.5B, 6.8B, 6.8C, 9.1A, 9.2C, 9.4A 4, 7, 10, 13, 17
Paste containing 4 – 6 g/litre abamectin and 40 – 70 g/litre praziquantel 6.1D, 6.4A, 6.8B, 6.8C, 9.1A, 9.2C, 9.3C, 9.4A 4, 7, 13, 17
Liquid containing 0.1 – 0.11% abamectin, 1.5 – 2% praziquantel and 0.03 – 0.055% selenium edentate 6.5B, 6.8B, 6.8C, 9.1A, 9.2C, 9.4A 4, 7, 10, 13, 17
Liquid containing 0.8 – 0.9 g/litre abamectin, 12 – 30 g/litre praziquantel and 0.9 – 1.5 g/litre sodium selenate 6.1E, 6.3B, 6.4A, 6.5B, 6.8B, 9.1A, 9.2C, 9.4A 4, 7, 10, 13, 17
Liquid containing 1 – 1.5 g/litre abamectin, 15 – 25 g/litre praziquantel and 0.2 – 0.6 g/litre selenium edetate 6.1E, 6.3A, 6.8B, 6.8C, 8.3A, 9.1A, 9.2C, 9.4A 4, 7, 13, 17
Liquid containing 0.05 – 0.09% abamectin and 0 – 0.07% sodium selenate (Substance A) 6.5B, 6.8B, 9.1A, 9.2C, 9.4A 4, 7, 10, 13, 17
Liquid containing 0.05 – 0.09% abamectin and 0 – 0.07% sodium selenate (Substance B) 6.3B, 6.4A, 6.5B, 6.8B, 9.1A, 9.2C, 9.4A 4, 7, 10, 13, 17
Liquid containing 0.1 – 0.12% abamectin and0.03 – 0.07% sodium selenate 6.3B, 6.4A, 6.5B, 6.8B, 6.8C, 9.1A, 9.2C, 9.4A 4, 7, 10, 13, 17
Liquid containing 1.12 – 1.5 g/litre abamectin and 2 – 4 g/litre selenium edetate 6.1E, 6.5B, 6.8B, 6.8C, 9.1A, 9.2C, 9.4A 4, 7, 10, 13, 17
Flammable liquid containing 4 – 7 g/litre abamectin and 270 – 330 g/litre triclabendazole 3.1D, 6.1D, 6.3B, 6.4A, 6.5B, 6.8B, 6.8C, 6.9B, 9.1A, 9.2C, 9.3B, 9.4A 4, 7, 10, 13, 17
Liquid containing 0.1 – 2% acepromazine maleate 6.9B 11
Paste containing 0.5 – 1.5% acepromazine maleate 6.9B 11
Liquid containing 95 – 100% acetylsalicylic acid 6.1C, 6.3B, 6.4A, 9.3B 4, 7, 11, 12, 17, 18, 22
Liquid containing 0.015 – 0.07% acriflavine, 0.05 – 0.25% malachite green and 0.01 – 0.05% quinine sulphate 9.1C 12
Liquid containing 2 – 4% aglepristone 6.8A, 9.1D 11, 12, 18
Liquid containing 1.5 – 3% albendazole (Substance A) 6.5B, 6.6B, 6.8A, 6.9B 4, 10
Liquid containing 1.5 – 3% albendazole (Substance B) 6.3B, 6.5B, 6.6B, 6.8A, 6.9B 4, 10
Solid containing 30 – 45% albendazole 6.1D, 6.5B, 6.6B, 6.8A, 6.9B, 9.3C 4, 5, 6, 10, 13, 31
Liquid containing 15 – 22 g/litre albendazole and 35 – 42 g/litre closantel sodium 6.5B, 6.6B, 6.8A, 6.9B, 9.1C 4, 10, 13
Liquid containing 17 – 23 g/litre albendazole, 0.5 – 0.9 g/litre ivermectin, 25 – 35 g/litre levamisole hydrochloride and 0.5 – 0.98 g/litre sodium selenate 6.1E, 6.4A, 6.5A, 6.5B, 6.6B, 6.8A, 6.9B, 9.1A, 9.2C, 9.4A 4, 7, 10, 13, 17
Liquid containing 17 – 23 g/litre albendazole, 0.5 – 0.9 g/litre ivermectin, 25 – 35 g/litre levamisole hydrochloride, 12 – 18 g/litre praziquantel and 0.5 – 0.98 g/litre sodium selenate 6.1E, 6.4A, 6.5A, 6.5B, 6.6B, 6.8A, 6.9B, 9.1A, 9.2C, 9.4A 4, 7, 10, 13, 17
Liquid containing 20 – 28 g/litre albendazole and 35 – 40 g/litre levamisole hydrochloride 6.1E, 6.3B, 6.5B, 6.6B, 6.8A, 6.9B 4, 10
Liquid containing 80 – 120 g/litre albendazole and 67 – 85 g/litre levamisole hydrochloride 6.1D, 6.3B, 6.5B, 6.6B, 6.8A, 6.9B, 9.3C 4, 10, 13
Liquid containing 20 – 30 g/litre albendazole, 35 – 40 g/litre levamisole hydrochloride and 15 – 23 g/litre praziquantel 6.1E, 6.3B, 6.5B, 6.6B, 6.8A, 6.9B 4, 10
Liquid containing 20 – 30 g/litre albendazole, 35 – 40 g/litre levamisole hydrochloride, 15 – 23 g/litre praziquantel and 0.6 – 1.8 g/litre sodium selenate 6.1E, 6.3B, 6.5B, 6.6B, 6.8A, 6.9B, 9.1A, 9.2C 4, 7, 10, 13, 17
Liquid containing 2 – 3% albendazole, 3.5 – 4% levamisole hydrochloride and 0.06 – 0.18% sodium selenate 6.1E, 6.3B, 6.5B, 6.6B, 6.8A, 6.9B, 9.1A, 9.2C 4, 7, 10, 13, 17
Liquid containing 20 – 30 g/litre albendazole and 15 – 23 g/litre praziquantel 6.3B, 6.5B, 6.6B, 6.8A, 6.9B 4, 10
Liquid containing 20 – 30 g/litre albendazole, 15 – 23 g/litre praziquantel and 0.6 – 1.8 g/litre sodium selenate 6.3B, 6.5B, 6.6B, 6.8A, 6.9B, 9.1A, 9.2C 4, 7, 10, 13, 17
Liquid containing 1.5 – 3% albendazole and 0.06 – 0.18% sodium selenate (Substance A) 6.3B, 6.5B, 6.6B, 6.8A, 6.9B, 9.1C 4, 10, 13
Liquid containing 1.5 – 3% albendazole and 0.06 – 0.18% sodium selenate (Substance B) 6.3B, 6.5B, 6.6B, 6.8A, 6.9B, 9.1A, 9.2C 4, 7, 10, 13, 17
Liquid containing 10 – 16% albendazole and 0.26 – 0.42% sodium selenate (Substance A) 6.1E, 6.3B, 6.5B, 6.6B, 6.8A, 6.9B, 9.1C, 9.2C 4, 10, 13
Liquid containing 10 – 16% albendazole and 0.26 – 0.42% sodium selenate (Substance B) 6.1D, 6.3B, 6.5B, 6.6B, 6.8A, 6.9B, 9.1A, 9.2C, 9.3C 4, 7, 10, 13, 17
Solid containing 30 – 40% albendazole and 0.3 – 0.8% sodium selenate (Substance A) 6.1D, 6.3B, 6.5B, 6.6B, 6.7B, 6.8A, 6.9B, 9.1B, 9.2C, 9.3C 4, 5, 6, 10, 13, 31
Solid containing 30 – 40% albendazole and 0.3 – 0.8% sodium selenate (Substance B) 6.1D, 6.5B, 6.6B, 6.8A, 6.9B, 9.1C, 9.2C, 9.3C 4, 5, 6, 10, 13, 31
Liquid containing 2 – 4 g/litre alfadolone acetate and 7 – 11 g/litre alfaxalone 6.9B 11
Liquid containing 1 – 15% alfaxalone 6.9B 11
Liquid containing 90 – 100% aliphatic polypropylene oxide polyethylene oxide polyether 6.1E, 6.4A, 9.1B 13
Cream containing 7 – 13 g/kg allantoin, 3 – 7 g/kg neomycin, 1.5 – 3.5 g/kg prednisolone and 14 – 24 g/kg undecylenic acid 6.1E, 6.3B, 6.5B, 6.8B, 6.9B 10, 11, 12
Liquid containing 20 – 50 g/litre alpha-cypermethrin 6.5B, 6.9B, 9.1A, 9.4A 4, 7, 10, 13, 17
Liquid containing 0.5 – 0.9% alpha-cypermethrin, 6 – 9% piperonyl butoxide and1.4 – 2.6% tetrachlorvinphos 6.1E, 6.3B, 6.4A, 6.5B, 6.8A, 9.1A, 9.4B 4, 7, 10, 13, 17
Liquid containing 0.15 – 0.25% altrenogest 6.8B 11
Flammable liquid containing 3 – 7 g/litre amethocaine hydrochloride, 170 – 230 g/litre embutramide and 40 – 60 g/litre mebezonium iodide 3.1C, 6.1D, 6.3B, 6.4A, 6.5B, 6.8A, 6.9A, 9.3C 2, 4, 10, 11, 12, 18
Cream containing 0.5 – 1.4 g/kg aminacrine hydrochloride, 3 – 6.5 g/kg cetrimide and 3 – 6.5 g/kg chlorhexidine diacetate 6.3B, 6.5B, 9.1B 6, 10, 11, 12, 34,
Liquid containing 10 – 13% amitraz 6.1D, 6.3A, 6.4A, 6.5B, 6.8B, 6.9A, 9.1A 4, 7, 10, 13, 17
Liquid containing 40 – 60 g/litre amitraz 6.1E, 6.3A, 6.4A, 6.5B, 6.8B, 6.9B, 9.1A 4, 7, 10, 13, 17
Liquid containing 50 – 60% ammonium lauryl ether sulphate and 0.5 – 1% triclosan 6.1D, 6.3A, 8.3A, 9.1A, 9.3C 4, 7, 11, 12, 17
Liquid containing 9 – 18% amoxycillin trihydrate 6.5B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Solid containing 30 – 50% amoxycillin trihydrate 6.5B, 9.1A 4, 5, 6, 7, 10, 11, 12, 17, 18, 22, 31
Solid containing 70 – 90% amoxycillin trihydrate 6.5A, 6.5B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 10 – 20% amoxycillin trihydrate and 1 – 5% clavulanic acid 6.5B, 6.9B, 9.1A, 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 3 – 12% amoxycillin trihydrate, 1 – 4% clavulanic acid and 0.2 – 0.4% prednisolone 6.5B, 6.8B, 6.9B, 9.1A, 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 10 – 20% amoxycillin trihydrate and 0.1 – 0.4% ethyl oleate 6.3B, 6.5B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 10 – 20% amoxycillin trihydrate and 3 – 6% potassium clavulanate 6.5B, 6.9B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Solid containing 20 – 60% amoxycillin trihydrate and 4 – 15% potassium clavulanate 6.5B, 6.9B, 9.1A 4, 5, 6, 7, 10, 11, 12, 17, 18, 22, 31
Solid containing 36 – 44% amoxycillin trihydrate and 18 – 26% potassium clavulanate 6.5A, 6.5B, 6.9B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 10 – 20% ampicillin 6.3A, 6.4A, 6.5B 10, 11
Liquid containing 3 – 8% ampicillin trihydrate and 10 – 16% cloxacillin benzathine 6.3B, 6.5B 10, 11
Solid containing 200 – 250 g/kg amprolium hydrochloride and 190 – 240 g/kg sulphaquinoxaline 6.1D, 6.3A, 6.4A, 6.9B, 9.1C 11, 12
Flammable cream containing 0.2 – 0.5% aniseed oil, 1 – 1.5% racementhol and 0.15 – 0.4% sassafras oil 3.1B, 6.3B, 6.4A, 6.7B, 9.1D 1, 2, 11, 12, 18
Solid containing 16 – 25% apomorphine hydrochloride 6.1E, 6.5B, 6.9A 4, 5, 6, 10, 11, 31
Liquid containing avian encephalomyelitis virus (attenuated) 9.3C 12, 18
Liquid containing 0.15 – 0.35% azaperone, 0.02 – 0.04% fentanyl citrate and 5.6 – 5.9% xylazine 6.1E, 6.3B, 6.4A, 6.5B, 6.6B, 6.7B, 6.9B 10, 11
Liquid containing 0.4 – 0.8% azaperone, 0.05 – 0.1% fentanyl citrate and 10 – 13% xylazine 6.1D, 6.3A, 6.4A, 6.5B, 6.6B, 6.7B, 6.9B, 9.3C 10, 11, 12, 18
Solid containing 5 – 15% bacitracin 6.3B, 6.5B 10, 11
Cream containing 0.5 – 1% bacitracin, 0.1 – 1% lignocaine, 0.3 – 0.7% neomycin sulphate, 1 – 3% nystatin and 0.05 – 0.15% triamcinolone acetonide 6.5B, 6.7B, 6.9B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Flammable liquid containing 10 – 20 g/litre balsam peru, 75 – 130 g/litre castor oil and 0.05 – 0.15 g/litre trypsin (Substance A) 3.1B, 6.1E, 6.5B, 6.8B, 6.9B, 9.1D 1, 2, 10, 11, 12, 34
Flammable liquid containing 10 – 20 g/litre balsam peru, 75 – 130 g/litre castor oil and 0.05 – 0.15 g/litre trypsin (Substance B) 3.1B, 6.3B, 6.4A, 6.5B, 9.1D 1, 2, 10, 11, 12, 34
Liquid containing 2.4 – 5% barium selenate 6.6B, 6.9B, 9.1B, 9.2B 11, 12, 20, 24
Liquid containing 15 – 18% barium selenate 6.1E, 6.4A, 6.6B, 6.9A, 9.1B, 9.2B, 4, 11, 12, 20, 24
Flammable liquid containing 30 – 60 g/litre bendiocarb 3.1C, 6.1D, 6.3B, 6.4A, 6.9B, 9.1D, 9.3B, 9.4A 2, 4, 7, 13, 17
Liquid containing 2.5 – 5.5% benzalkonium chloride 6.1E, 6.5A, 6.5B, 6.9B, 8.2C, 8.3A, 9.1A, 9.3C 4, 7, 10, 11, 12, 17
Cream containing 0.4 – 1.2 g/kg benzalkonium chloride, 1 – 5 g/kg cetrimide, 110 – 170 g/kg titanium dioxide and 60 – 100 g/kg zinc oxide 6.3B, 6.5B, 9.1A 4, 6, 7, 10, 11, 12, 17, 34
Liquid containing 0.005 – 0.015% benzalkonium chloride, 0.02 – 0.08% edetic acid and 1 – 3% fusidic acid hemihydrate 6.9B 11
Solid containing 0.7 – 1.3% benzocaine, 1 – 2.4% chlortetracycline hydrochloride and 1 – 3% magnesium oxide 6.3B, 6.5B, 6.9B, 9.1D 5, 6, 10, 11, 12, 18, 31
Flammable liquid containing 5.5 – 8.5% benzoic acid, 1 – 1.5% copper hydroxide and 0.5 – 1.5% methyl salicylate 3.1C, 6.3B, 6.4A, 6.5B, 9.1A, 9.3C 2, 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 2.5 – 4.5% benzoyl peroxide 6.3A, 6.4A, 6.5B, 9.1D 10, 11, 12
Liquid containing 6 – 8% benzylpenicillin sodium, 4 – 6% dihydrostreptomycin sulphate and 4 – 6% nafcillin sodium 6.3A, 6.4A, 6.5B, 6.8A, 6.9B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Cream containing 0.1 – 0.3% betamethasone valerate, 0.7 – 1.3% clotrimazole and 0.2 – 0.5% gentamicin sulphate 6.5B, 6.8B 10, 11
Gel containing 0.1 – 0.3% betamethasone valerate and 0.3 – 0.7% fusidic acid hemihydrate 6.8B, 6.9B 11
Cream containing 600 – 700 g/kg bismuth subnitrate 5.1.1B 3
Liquid containing 2 – 10% boric acid (Substance A) 6.8B 11
Liquid containing 2 – 10% boric acid (Substance B) 6.3A, 6.4A, 6.8B 11
Liquid containing 0.8 – 1.5% boric acid, 0.05 – 0.15% camphor oil and 0.1 – 0.25% zinc sulphate 6.5B, 6.8B 10, 11
Liquid containing 0.2 – 0.4% bromhexine hydrochloride, 1 – 3% lignocaine and 3 – 7% oxytetracycline hydrochloride 6.3A, 6.4A, 6.5B, 6.6B, 6.7B, 6.8B, 6.9B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Solid containing 0.4 – 0.8% bromhexine hydrochloride, 64 – 74% sulphadiazine and 11 – 21% trimethoprim 6.1D, 6.3A, 6.4A, 6.5A, 6.5B, 6.9B, 9.1A, 9.3C 4, 7, 10, 11, 12, 17, 18, 22
Solid containing 0.5 – 1.2% bromhexine hydrochloride, 38 – 48% sulphamethazine and 6 – 10% trimethoprim 6.8B, 6.9B 5, 6, 11
Cream containing 0.1 – 0.4% bronopol 9.1D 12, 34
Liquid containing 1 – 1.5% butorphanol tartrate 6.9B 11
Liquid containing 10 – 15% C10 – C16 ethoxylated alcohol, 80 – 90% ethylene oxide propylene copolymer and 1 – 1.5% minerals 6.1D, 6.3B, 6.4A, 6.5B, 6.9B, 9.1A, 9.3C 4, 7, 10, 13, 17
Liquid containing 20 – 25% C10 – C16 ethoxylated alcohol, 25 – 30% ethylene oxide propylene oxide copolymer and 25 – 30% nonylphenol ethoxylate 6.1D, 6.3B, 6.4A, 9.1B, 9.3C 13
Liquid containing 10 – 15% C10 – C16 ethoxylated alcohol and 80 – 90% ethylene oxide propylene copolymer 6.1E, 6.3B, 6.4A, 9.1D 13
Liquid containing 77 – 85% C12 – C14 ethoxylated alcohol 6.1D, 6.3B, 6.4A, 9.1D, 9.3B 13
Liquid containing 90 – 95% C12 – C15 ethoxylated propoxylated alcohol 6.1D, 6.3B, 6.4A, 9.1A, 9.3C 4, 7, 13, 17
Liquid containing 68 – 75% C12 – C15 ethoxylated propoxylated alcohol and 5 – 9% ethylene oxide propylene oxide copolymer 6.1D, 6.3B, 6.4A, 9.1A, 9.3C 4, 7, 13, 17
Cream containing 9 – 14% calamine, 10 – 15% sulphanilamide and 18 – 28% zinc oxide 6.3A, 6.4A, 9.1A, 9.3C 4, 7, 11, 12, 17, 18, 22
Cream containing 3.5 – 7% camphor oil, 0.2 – 0.7% cedarwood oil, 0.2 – 0.7% nutmeg oil, 2 – 3% racementhol and 3 – 5.5% terebinth oil 6.3B, 6.4A, 6.5B, 6.9B, 9.1C 10, 11, 12, 18, 22
Cream containing 1 – 1.5% camphor oil, 1.5 – 2.5% methyl salicylate and 0.5 – 1.5% racementhol 6.5B, 6.9B, 9.1D 10, 11, 12, 18
Solid containing 4 – 7% carbadox and 2 – 5% morantel citrate 6.1E, 6.4A, 6.6B, 6.7A, 6.9B 4, 5, 6, 9, 31
Aerosol containing 0.3 – 0.7% carbaryl and 0.4 – 0.8% piperonyl butoxide 6.1D, 6.3A, 6.4A, 6.7B, 6.8B, 6.9A, 9.1C, 9.3C, 9.4C 4, 13
Liquid containing 30 – 60 g/kg carprofen 6.1E, 6.9B 11
Solid containing 30 – 60 g/kg carprofen 6.1E, 6.9B 5, 6, 11
Solid containing 100 – 350 g/kg carprofen 6.1D, 6.9B, 9.3C 5, 6, 11, 12, 18
Substance containing 1 – 80% cefadroxil monohydrate 6.5B 5, 6, 10, 11
Liquid containing 3 – 7% ceftiofur 6.9B 11
Solid containing 90 – 95% ceftiofur 6.3A, 6.4A, 6.9B 5, 6, 11, 31
Solid containing 96 – 100% ceftiofur 6.9B 5, 6, 11
Liquid containing 9.2 – 9.5% cefuroxime sodium 6.3B, 6.5B 10, 11
Liquid containing 1 – 30% cephalexin 6.5B 10, 11
Paste containing 10 – 25% cephalexin 6.5B 10, 11
Solid containing 35 – 70% cephalexin 6.1E, 6.5B 5, 6, 10, 11, 31
Solid containing 85 – 95% cephalexin 6.1D, 6.5B, 9.3C 5, 6, 10, 11, 12, 18, 31
Liquid containing 3 – 7% cephalexin and 3 – 7% dihydrostreptomycin sulphate 6.5B, 6.8A, 6.9B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 1 – 4% cephalexin and 1 – 3% kanamycin sulphate 6.5B, 6.8A, 6.9B 10, 11
Liquid containing 2 – 6% cephapirin benzathine 6.3B, 6.5B, 6.9B 10, 11
Cream containing 3 – 7% cetostearyl alcohol, 1 – 1.5% cetrimide and 0.3 – 0.7% chlorhexidine 6.3A, 6.4A, 6.5B, 9.1B 6, 10, 11, 12, 34
Cream containing 0.5 – 0.7% g/kg cetrimide 6.3B, 6.4A, 6.5B, 9.1B 6, 10, 11, 12, 34
Cream containing 3 – 7 g/kg cetrimide, 0.5 – 1.5 g/kg chlorhexidine gluconate, 10 – 18 g/kg titanium dioxide and 65 – 95 g/kg zinc oxide 6.3B, 6.5B, 9.1A 4, 6, 7, 10, 11, 12, 17, 34
Flammable liquid containing 6 – 9.5 g/litre cetrimide, 1.7 – 3.1 g/litre chloroxylenol, 1.8 – 3.2 g/litre di-N-propylisocinchomeronate, 3 – 7 g/litre N-octyl bicycloheptene dicarboxamide, 0.5 – 1.1 g/litre orthophenyl phenol and 0.25 – 0.45 g/litre pyrethrins 3.1B, 6.1E, 6.4A, 6.5B, 6.7B, 6.8B, 6.9A, 9.1B, 9.4C, 1, 2, 4, 10, 11, 12, 34
Flammable liquid containing 7 – 13 g/litre cetrimide, 565 – 655 g/litre ethanol, 0.3 – 1 g/litre methyl salicylate and 3 – 7 g/litre phenol 3.1C, 6.3A, 6.4A, 6.5B, 9.1B 2, 10, 11, 12, 34
Cream containing 0.3 – 0.7% cetrimide and 0.7 – 1.3% octyldimethyl p-aminobenzoate 6.5B, 6.8B, 9.1B 6, 10, 11, 12, 34
Cream containing 3 – 7 g/kg cetrimonium bromide and 0.6 – 1.8 g/kg chlorhexidine gluconate 6.3B, 6.5B, 9.1B 6, 10, 11, 12, 34
Solid containing 950 – 1000 g/kg chloramine T 6.1D, 6.5A, 6.5B, 6.9B, 8.2C, 8.3A, 9.1D, 9.3C 10, 11, 12, 34
Liquid containing 900 – 1100 g/litre chlorfenvinphos 6.1A, 6.3B, 6.4A, 6.9A, 9.1A, 9.3A, 9.4B 4, 9, 13
Liquid containing 0.6 – 1.4% chlorhexidine gluconate 6.3B, 9.1B 11, 12, 34
Liquid containing 1.5 – 2.25% chlorhexidine gluconate (Substance A) 9.1B 12, 34
Liquid containing 1.5 – 2.25% chlorhexidine gluconate (Substance B) 6.3B, 6.4A, 9.1B 11, 12, 34
Liquid containing 3 – 6.5% chlorhexidine gluconate 9.1A 4, 7, 12, 17, 34
Liquid containing 25 – 35 g/litre chlorhexidine gluconate 6.3B, 6.4A, 6.5B, 9.1A 4, 7, 10, 11, 12, 17
Foam containing 15 – 25 g/litre chlorhexidine gluconate and 15 – 25 g/litre miconazole nitrate 6.1E, 6.3A, 6.4A, 6.5B, 6.8B, 9.1A 4, 7, 10, 11, 12, 17, 34
Liquid containing 17 – 25 g/litre chlorhexidine gluconate, 17 – 25 g/litre miconazole nitrate and 2 – 3.5 g/litre selenium sulphide 6.1E, 6.3A, 6.7B, 6.8A, 8.3A, 9.1B 4, 11, 12
Solid containing 1.5 – 1.9% chlorpheniramine maleate and 4 – 5% prednisolone 6.8B, 6.9B 5, 6, 11
Solid containing 1 – 1.6% chlorpheniramine maleate and 2.5 – 4.5% prednisolone acetate 6.8B, 6.9B 5, 6, 11
Flammable liquid containing 32 – 50% chlorpyrifos 3.1D, 6.1C, 6.3A, 6.7B, 6.8B, 6.9A, 8.3A, 9.1A, 9.2B, 9.3A, 9.4A 4, 9, 13
Flammable liquid containing 120 – 180 g/litre chlorpyrifos 3.1D, 6.1D, 6.3A, 6.7B, 6.8B, 6.9A, 8.3A, 9.1A, 9.2C, 9.3B, 9.4A 4, 7, 13, 17
Flammable liquid containing 7 – 13 g/litre chlorpyrifos and 100 – 120 g/litre cypermethrin 3.1D, 6.1D, 6.3B, 6.4A, 6.5B, 6.8B, 6.9A, 9.1A, 9.3C, 9.4A 4, 7, 10, 13, 17
Solid containing 10 – 15% chlortetracycline hydrochloride and 1 – 5% tiamulin hydrogen fumarate 6.3A, 6.4A, 6.9B, 9.1A 4, 7, 11, 12, 17
Solid containing 0.001 – 0.004% clenbuterol, 30 – 37% sulphadiazine and 4 – 8% trimethoprim 6.1E, 6.3A, 6.4A, 6.5A, 6.5B, 6.9B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Solid containing 1 – 9.5% clindamycin hydrochloride 6.3B 5, 6, 11, 31
Liquid containing 2.6 – 4% clindamycin hydrochloride 6.3B, 6.4A 11
Solid containing 10 – 40% clindamycin hydrochloride 6.3B, 6.4A 5, 6, 11, 31
Solid containing 30 – 50 g/kg clomipramine hydrochloride 6.9B 5, 6, 11
Solid containing 100 – 130 g/kg clomipramine hydrochloride 6.9A 4, 5, 6, 11
Solid containing 190 – 260 g/kg clomipramine hydrochloride 6.1E, 6.9A 4, 5, 6, 11
Liquid containing 0.005 – 0.03% cloprostenol sodium 6.8A, 6.9A 4, 11
Device containing 0.85 – 0.95% cloprostenol sodium, 2.7 – 3.3% oestradiol and 2 – 6% progesterone 6.7A, 6.8A, 6.9A 4, 5, 6, 7, 11, 32
Liquid containing 80 – 120 g/litre clorsulon and 10 – 13 g/litre ivermectin (Substance A) 6.1D, 6.6B, 6.8B, 6.8C, 6.9B, 9.1A, 9.2C, 9.3C, 9.4A 4, 7, 13, 17
Liquid containing 80 – 120 g/litre clorsulon and 10 – 13 g/litre ivermectin (Substance B) 6.1D, 6.4A, 6.5B, 6.6B, 6.8B, 6.8C, 6.9A, 9.1A, 9.2C, 9.3C, 9.4A 4, 7, 10, 13, 17
Liquid containing toxoid/cells from species of the Clostridium genus, Corynebacterium pseudotuberculosis exotoxin and 0.25% sodium selenate 6.5B, 9.2C 10, 11, 12, 18, 22
Liquid containing toxoid/cells from species of the Clostridium genus and 7 – 11% levamisole phosphate 6.1E, 6.5B, 6.6B, 6.9B 10
Liquid containing toxoid/cells from species of the Clostridium genus and 7 – 11% levamisole phosphate and 0.06 – 0.2% sodium selenate 6.1E, 6.5B, 6.6B, 6.9B 10
Liquid containing toxoid/cells from species of the Clostridium genus and 0.25% sodium selenate 6.5B, 9.2C 10, 11, 12, 18, 22
Liquid containing toxoid/cells from species of the Clostridium genus and 0.5 – 0.8% sodium selenate (Substance A) 6.1E, 6.5B, 9.1C, 9.2C 10, 11, 12, 18, 22
Liquid containing toxoid/cells from species of the Clostridium genus and 0.5 – 0.8% sodium selenate (Substance B) 6.1E, 9.1C, 9.2C 11, 12, 18, 22
Liquid containing toxoid/cells from species of the Clostridium genus and 1.0 – 1.2% sodium selenate 6.1E, 6.5B, 6.6B, 6.9B, 9.1C, 9.2C 10, 11, 12, 18, 22
Liquid containing 10 – 30% cloxacillin benzathine 6.5B 10, 11
Liquid containing 6 – 10% cloxacillin benzathine and 1 – 3% cloxacillin sodium monohydrate 6.3B, 6.5B 10, 11
Liquid containing 1 – 4% cloxacillin sodium and 1 – 4% neomycin sulphate 6.3B, 6.5B, 6.9B 10, 11
Liquid containing 7 – 9% cloxacillin sodium monohydrate 6.3B, 6.4A, 6.5B 10, 11
Liquid containing 2 – 6% cloxacillin sodium monohydrate and 0.5 – 2% sodium ampicillin 6.3B, 6.5B 10, 11
Liquid containing 70 – 90 g/litre copper chloride dihydrate and 450 – 465 g/litre copper nitrate trihydrate 5.1.1B, 6.1D, 6.5B, 6.9B, 8.1A, 8.2C, 8.3A, 9.1A, 9.3C 3, 4, 7, 10, 11, 12, 17
Paste containing 3 – 5% copper indomethacin 6.3B, 6.4A 11
Capsule containing 80 – 100% copper oxide 6.1E, 6.4A, 6.9B, 9.1A, 4, 5, 6, 7, 11, 12, 17, 20, 24, 31
Flammable liquid containing 150 – 225 g/litre copper naphthenate 3.1C, 6.1E, 6.3B, 6.4A, 9.1B, 2, 11, 12, 34
Cream containing 100 – 120 g/kg copper sulphate 6.1D, 6.3A, 6.4A, 6.5B, 6.9B, 9.1A, 9.3C 4, 7, 10, 11, 12, 17, 34
Cream containing 7 – 13 g/kg copper sulphate, 275 – 360 g/kg sulphur and 15 – 25 g/kg tar acids 6.1E, 6.3A, 6.4A, 6.5B, 6.6B, 6.8B, 6.9B, 9.1A 4, 7, 10, 11, 12, 17, 34
Flammable liquid containing 13 – 16.5% coumaphos 3.1D, 6.1B, 6.3B, 6.4A, 6.9A, 9.1A, 9.3A, 9.4C 4, 9, 13
Liquid containing 48 – 65 g/litre coumaphos 6.1C, 6.4A, 6.9B, 9.1A, 9.3A, 9.4C 4, 8, 13, 17
Solid containing 2.6 – 3% coumaphos, 1 – 2.5% propoxur and 3 – 7% sulphanilamide 6.1D, 6.3B, 6.4A, 6.7B, 6.9B, 9.1A, 9.3A, 9.4C 4, 5, 6, 7, 13, 17, 18, 22, 31
Solid containing 5.5 – 9.5% cyclosporin 6.7A, 6.9B 4, 5, 6, 7, 11
Liquid containing 10 – 12 g/litre cyfluthrin 6.3B, 6.4A, 6.8C, 6.9B, 9.1A, 9.4A 4, 7, 13, 17
Flammable liquid containing 40 – 65 g/litre cyhalothrin 3.1D, 6.1D, 6.3B, 6.5B, 6.9B, 8.3A, 9.1A, 9.3C, 9.4A 4, 7, 10, 13, 17
Liquid containing 10 – 14 g/litre cypermethrin 6.1D, 6.3B, 6.4A, 6.5B, 6.8B, 6.9B, 9.1A, 9.3C, 9.4B 4, 7, 10, 13, 17
Liquid containing 18 – 25 g/litre cypermethrin 6.5B, 6.8B, 6.9B, 9.1A, 9.4A 4, 7, 10, 13, 17
Flammable liquid containing 16 – 24 g/litre cypermethrin 3.1D, 6.1E, 6.3B, 6.4A, 6.5B, 6.8B, 6.9B, 9.1A, 9.4A 4, 7, 10, 13, 17
Liquid containing 40 – 60 g/litre cypermethrin 6.1E, 6.5B, 6.8B, 6.9B, 9.1A, 9.4A 4, 7, 10, 13, 17
Flammable liquid containing 40 – 60 g/litre cypermethrin 3.1D, 6.1D, 6.3B, 6.4A, 6.5B, 6.8B, 6.9B, 9.1A, 9.4A 4, 7, 10, 13, 17
Liquid containing 100 – 120 g/litre cypermethrin 6.1D, 6.5B, 6.8A, 6.9A, 8.2B, 8.3A, 9.1A, 9.3C, 9.4A 4, 7, 10, 13, 17
Solid containing 100 – 144 g/kg zeta-cypermethrin and 170 – 230 g/kg piperonyl butoxide 6.1D, 6.3B, 6.4A, 6.5B, 6.8B, 6.9A, 9.1A, 9.3C, 9.4A 4, 5, 6, 7, 10, 13, 17, 31
Liquid containing 42 – 78 g/litre cyromazine (Substance A) 6.3A, 6.4A, 6.9B, 9.1D 13
Liquid containing 42 – 78 g/litre cyromazine (Substance B) 6.3A, 6.4A, 6.8A, 6.9B, 9.1D 4, 13
Liquid containing 42 – 78 g/litre cyromazine (Substance C) 6.3A, 6.9B, 8.3A, 9.1C 13
Liquid containing 450 – 550 g/litre cyromazine 6.1E, 6.9B, 9.2C, 9.4C 13
Liquid containing 0.7 – 1.3% delmadinone acetate 6.7B, 6.8B 11
Liquid containing 10 – 15 g/litre deltamethrin (Substance A) 6.5B, 6.9B, 9.1A, 9.4A 4, 7, 10, 13, 17
Liquid containing 10 – 15 g/litre deltamethrin (Substance B) 6.1D, 6.3B, 6.4A, 6.9B, 9.1A, 9.2C, 9.3C, 9.4A 4, 7, 13, 17
Liquid containing 10 – 13 g/litre detomidine hydrochloride 6.1D, 6.9B, 9.3C 11, 12, 18
Liquid containing 0.1 – 0.6% dexamethasone ester 6.8B 11
Liquid containing 0.05 – 0.15% dexamethasone, 25% dihydrostreptomycin sulphate, 16 – 24% penicillin g procaine and 1 – 3% tripelennamine 6.1D, 6.5B, 6.8A, 6.9A, 9.1A, 9.3B 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 0.1 – 1.7 g/litre dexamethasone, 38 – 41 g/litre lignocaine, 43 – 52 g/litre monosulfiram, 4 – 11 g/litre neomycin sulphate and 0.7 – 2 g/litre polymyxin 6.1D, 6.3B, 6.5B, 6.6B, 6.7B, 6.9B, 9.1B, 9.3C 10, 11, 12, 18, 22
Liquid containing 0.3 – 0.7% diazepam 6.4A, 6.8B, 6.9B, 9.1C 11, 12, 18, 22
Solid containing 20 – 50 g/kg diazinon 6.4A, 6.8B, 6.9B, 9.1A, 9.3A, 9.4A 4, 5, 6, 7, 13, 17, 31
Collar containing 140 – 180 g/kg diazinon 6.4A, 9.1A, 9.4A 4, 5, 7, 11, 12, 17, 18, 22
Flammable liquid containing 360 – 440 g/litre diazinon 3.1D, 6.1D, 6.3B, 6.4A, 6.7B, 6.8B, 6.9A, 9.1A, 9.2D, 9.3A, 9.4A 4, 7, 13, 17
Collar containing 140 – 180 g/kg diazinon and 1.7 – 3.2 g/kg pyriproxyfen 6.4A, 9.1A, 9.4A 4, 5, 7, 11, 12, 17, 18, 22
Flammable liquid containing 14 – 26 g/litre dibutylphthalate, 35 – 65 g/litre N,N-diethyl-3-methylbenzamide, 17 – 32 g/litre N-octyl bicycloheptene dicarboximide, 10 – 20 g/litre permethrin and 17 – 32 g/litre piperonyl butoxide 3.1B, 6.4A, 6.5A, 6.5B, 6.8A, 6.9B, 9.1A, 9.4B 1, 2, 4, 7, 10, 13, 17
Liquid containing 35 – 45% p-dichlorobenzene and 1.2 – 2% propetamphos 6.1E, 6.3A, 6.4A, 6.7B, 6.9B, 9.1A, 9.4C 4, 7, 13, 17
Flammable aerosol containing 5 – 10% dichlorophen 2.1.2A, 6.4A, 9.1A 1, 4, 7, 11, 12, 17, 34
Liquid containing 10 – 12% dicloxacillin sodium and 2 – 4% ampicillin sodium 6.3A, 6.4A, 6.5B 10, 11
Liquid containing 35 – 65 g/litre dicyclanil 6.9B, 9.1C 13
Solid containing 50 – 80 g/kg didecyl dimethyl ammonium bromide and 80 – 120 g/kg oxytetracycline hydrochloride 6.1E, 6.5B, 8.2B, 8.3A, 9.1A 4, 5, 6, 7, 10, 11, 12, 17, 18, 22, 31
Solid containing 8 – 12% difloxacin hydrochloride 6.9B, 9.1D 5, 6, 11, 12, 18
Flammable liquid containing 1 – 3% diflubenzuron 3.1D, 6.3A, 6.4A, 6.8A, 6.9B, 9.1A 4, 7, 13, 17
Liquid containing 1.7 – 3.2% diflubenzuron 6.9B, 9.1A 4, 7, 13, 17
Liquid containing 20 – 30% diflubenzuron (Substance A) 6.4A, 6.9B, 9.1A 4, 7, 13, 17
Liquid containing 20 – 30% diflubenzuron (Substance B) 6.3B, 6.4A, 6.5B, 6.9B, 9.1A 4, 7, 10, 13, 17
Liquid containing 20 – 30% diflubenzuron (Substance C) 6.4A, 6.5B, 6.9B, 9.1A 4, 7, 10, 13, 17
Liquid containing 2 – 4% dihydrostreptomycin sulphate, 0.7 – 1.3% framycetin sulphate, 2 – 4% penethamate hydriodide and 0.05 – 1.3% prednisolone 6.5B, 6.8A, 6.9B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 3 – 5% dihydrostreptomycin sulphate, 3 – 5% nafcillin sodium and 8 – 12% penicillin g procaine 6.3B, 6.5B, 6.8A, 6.9B, 9.1A, 9.3C 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 0.7 – 1.3% dihydrostreptomycin sulphate, 1 – 2% neomycin sulphate, 0.7 – 1.3% novobiocin sodium and 0.06 – 0.2% prednisolone 6.5B, 6.8A, 6.9B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 25 – 30% dihydrostreptomycin sulphate, 10 – 20% penicillin benethamine and 10 – 20% penicillin g procaine 6.1D, 6.5B, 6.7B, 6.8A, 6.9A, 9.1A, 9.3B 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 23 – 25% dihydrostreptomycin sulphate, 8 – 15% penicillin g benzathine and 8 – 15% penicillin g procaine (Substance A) 6.1D, 6.5B, 6.8A, 6.9A, 9.1A, 9.3C 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 23 – 25% dihydrostreptomycin sulphate, 8 – 15% penicillin g benzathine and 8 – 15% penicillin g procaine (Substance B) 6.1C, 6.5B, 6.8A, 6.9A, 9.1A, 9.3C 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 26 – 32% dihydrostreptomycin sulphate, 4 – 8% penicillin g benzathine and 6 – 10% penicillin g procaine 6.1D, 6.5B, 6.8A, 6.9A, 9.1A, 9.3B 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 10 – 16% dihydrostreptomycin sulphate and 17 – 25% penicillin g procaine 6.1E, 6.5B, 6.8A, 6.9A, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 16.3 – 20% dihydrostreptomycin sulphate and 21 – 32% penicillin g procaine 6.1D, 6.5B, 6.8A, 6.9A, 9.1A, 9.3C 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 25 – 30% dihydrostreptomycin sulphate and 20 – 30% penicillin g procaine (Substance A) 6.1D, 6.5B, 6.8A, 6.9A, 9.1A, 9.3B 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 25 – 30% dihydrostreptomycin sulphate and 20 – 30% penicillin g procaine (Substance B) 6.1D, 6.5B, 6.8A, 6.9A, 9.1A, 9.3C 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 33 – 38% dihydrostreptomycin sulphate and 16 – 24% penicillin g procaine 6.1C, 6.5B, 6.8A, 6.9A, 9.1A, 9.3B 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 13 – 16% dihydrostreptomycin sulphate and 13 – 16% streptomycin 6.1D, 6.5B, 6.8A, 6.9A, 9.1A, 9.3B 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 16.5 – 30% dihydrostreptomycin sulphate and 16.5 – 30% streptomycin 6.1C, 6.5B, 6.8A, 6.9A, 9.1A, 9.3B 4, 7, 10, 11, 12, 17, 18, 22
Flammable gel containing 85 – 95% dimethyl sulfoxide 3.1D, 6.3B, 6.4A, 9.3B 11, 12, 18, 22
Solid containing 10 – 30% dimetridazole 6.3A, 6.4A 11
Solid containing 36 – 60% dimetridazole 6.1E, 6.3A, 6.4A 11
Liquid containing 0.4 – 0.8% dinoprost tromethamine 6.8A, 6.9A 4, 11
Liquid containing 450 – 550 g/litre dipyrone and 2 – 6 g/litre hyoscine n-butyl bromide 6.1D, 6.5B, 9.3C 10, 11, 12, 18
Liquid containing 8 – 12% dodecyl benzene sulphonic acid 6.3A, 8.3A, 9.1D 11, 12, 34
Flammable liquid containing 0.5 – 0.8% doramectin 3.1B, 6.1E, 6.3B, 6.4A, 6.8B, 6.8C, 9.1A, 9.2C, 9.4A, 1, 2, 4, 7, 13, 17
Liquid containing 0.5 – 0.8% doramectin 6.5B, 6.8B, 6.8C, 9.1A, 9.2C, 9.4A 4, 7, 10, 13, 17
Liquid containing 1 – 1.3% doramectin 6.1E, 6.8B, 6.8C, 6.9B, 9.1A, 9.2C, 9.4A 4, 7, 13, 17
Liquid containing 1.7 – 3% doxapram hydrochloride 6.9B 11
Solid containing 2.6 – 8% doxycycline 6.3B, 6.5B, 6.9B, 9.1B 5, 6, 10, 11, 12, 18, 22, 31
Paste containing 10 – 18% doxycycline 6.3B, 6.4A, 6.5B, 6.9B, 9.1B 10, 11, 12, 18, 22
Solid containing 30 – 48% doxycycline 6.1E, 6.3B, 6.4A, 6.5B, 6.9B, 9.1A, 9.3C 4, 5, 6, 7, 10, 11, 12, 17, 18, 22, 31
Solid containing 60 – 75% dyprone and 1.5 – 3.5% hyoscine n-butyl bromide 6.1D, 6.5B, 9.3C 5, 6, 10, 11, 12, 18, 31
Liquid containing 48 – 70 g/litre eltenac 6.1D, 6.3A, 6.4A, 6.8A, 6.9B, 9.3C 4, 11, 12, 18
Liquid containing 1 – 5% enrofloxacin 6.3B, 6.9B, 8.3A 11
Liquid containing 6 – 15% enrofloxacin 6.1E, 6.3A, 6.9B, 8.3A 11
Solid containing 25% enrofloxacin 6.1D, 6.9B, 9.3C 5, 6, 11, 12, 18
Solid containing 26 – 50% enrofloxacin 6.1D, 6.9B, 9.1D, 9.3C 5, 6, 11, 12, 18
Liquid containing 0.3 – 0.7% enrofloxacin and 0.7 – 1.3% silver sulphadiazine 6.3B, 6.5B, 9.1D 10, 11, 12, 18
Liquid containing 0.5 – 1% epidermal growth factor 6.9B 11
Liquid containing 0.3 – 0.7% eprinomectin 6.8B, 9.1A, 9.2C, 9.3C, 9.4A 4, 7, 13, 17
Solid containing 30 – 80% erythromycin thiocyanate 6.3B, 6.4A, 9.1D 5, 6, 11, 12, 18, 31
Solid containing 360 – 400 g/kg etamiphylline camasylate 6.1E 5, 11
Flammable liquid containing 3 – 7% ethanol and 16 – 24% formaldehyde 3.1D, 6.1D, 6.5B, 6.6B, 6.7A, 6.9B, 8.2C, 8.3A, 9.1D, 9.2B, 9.3C 4, 9, 10, 11, 12
Liquid containing 85 – 95% ethylene oxide propylene oxide copolymer 6.4A
Liquid containing 53 – 63% ethylene oxide propylene oxide copolymer and 30 – 40% nonylphenol ethoxylate 6.1E, 6.3B, 6.4A, 9.1B 13
Liquid containing 57 – 67% ethylene oxide propylene oxide copolymer and 35 – 45% nonylphenol ethoxylate. Also contains selenium oxide 6.1E, 6.3B, 6.4A, 6.5B, 9.1A 4, 7, 13, 17
Paste containing 0.2 – 0.5% ethyloestrenol 6.7B, 6.8A 4, 11
Solid containing 55 – 65% etodolac 6.1C, 6.8B, 6.9B, 9.3B 4, 5, 6, 7, 11, 12, 17, 18, 22
Liquid containing 500 – 600 g/litre etofenprox and 45 – 55 g/litre pyriproxyfen 6.8C, 6.9B, 9.1A, 9.2B, 9.4C 4, 7, 13, 17
Paste containing 0.5 – 1.5% eucalyptus oil, 0.5 – 1.5% fennel oil, 45 – 60% magnesium trisilicate and 0.5 – 1.5% racementhol 6.3B, 6.5B 10, 11
Liquid containing 45 – 55% fatty acids 9.1D 12, 34
Solid containing 18 – 40% febantel, 6 – 9% praziquantel and 16 – 24% pyrantel pamoate 6.8B, 6.9B 5, 6
Liquid containing 1.7 – 3.3% fenbendazole 6.3B, 6.9B
Liquid containing 8 – 12% fenbendazole 6.9B
Liquid containing 17 – 33 g/litre fenbendazole, 40 – 60 g/litre levamisole hydrochloride and 1.5 – 2.3 g/litre sodium selenate 6.1E, 6.3B, 6.4A, 6.5B, 6.6B, 6.9B 10
Liquid containing 17 – 33 g/litre fenbendazole and 0.9 – 1.8 g/litre sodium selenate 6.3B, 6.4A, 6.9B, 9.1C, 9.2C 13
Liquid containing 80 – 120 g/litre fenbendazole and 2.6 – 4 g/litre sodium selenate 6.3A, 6.4A, 6.5B, 6.7B, 6.8B, 6.9B, 9.1B, 9.2C 10, 13
Flammable liquid containing 100 – 202 g/litre fenthion 3.1D, 6.1E, 6.6B, 6.9A, 9.1A, 9.3B, 9.4A 4, 7, 13, 17, 19, 23
Flammable liquid containing 0.25 – 0.38% fipronil 3.1B, 6.1E, 6.3B, 6.4A, 9.1B, 9.3C, 9.4A 1, 2, 4, 7, 13, 17, 19, 23
Flammable liquid containing 80 – 101 g/litre fipronil 3.1C, 6.1D, 6.3B, 6.4A, 6.9B, 9.1A, 9.3B, 9.4A 2, 4, 7, 13, 17, 19, 23
Liquid containing 1 – 3% florfenicol 6.9B, 9.1B 11, 12, 18, 22
Liquid containing 26 – 36% florfenicol 6.3A, 6.4A, 6.8A, 6.9B, 9.1A 4, 7, 11, 12, 17, 18, 22
Solid containing 3 – 7% flubendazole 6.9B 5, 6
Liquid containing 1 – 1.3% flumethrin 6.9B, 9.1C, 9.4C 13
Flammable liquid containing 60 – 90 g/litre flumethrin 3.1C, 6.1D, 6.3B, 6.9B, 8.3A, 9.1B, 9.3B, 9.4B 2, 13
Liquid containing 5 – 9.5% flunixin meglumine 6.1D, 6.9B, 9.3C 11, 12, 18
Gel containing 6 – 9.5% flunixin meglumine 6.1D, 6.9B, 9.3C 11, 12, 18
Implant containing 95 – 97% flurogestone acetate 6.9A 4, 5, 6, 11, 32
Solid containing 40 – 100% follicle stimulating hormone 6.8B 5, 6, 11
Solid containing 22 – 28 IU/ml follicle stimulating hormone and 22 – 28 IU/ml luteinising hormone 6.8B 5, 6, 11
Liquid containing 0.3 – 0.7% framycetin sulphate, 0.3 – 0.7% fucidin, 16 – 24% nystatin and 0.1 – 0.4% prednisolone 6.5B, 6.8B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 1 – 3% framycetin sulphate, 1 – 3% penethamate hydriodide and 3 – 7% penicillin benethamine 6.5B, 6.9B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Solid containing 20 – 28% frusemide 6.1D, 9.3C 5, 6, 11, 12, 18
Liquid containing 1 – 10 g/litre frusemide diethanolamine 6.5B, 9.1C 10, 11, 12, 18, 22
Solid containing 10 – 22% furazolidone 6.5B, 6.6B, 6.8B, 9.1A 4, 7, 10, 11, 12, 17
Solid containing 3 – 7% furazolidone and 9 – 13% nitrofurazone 6.1E, 6.5B, 6.6B, 6.8B, 6.9B, 9.1A, 9.3B 4, 5, 6, 7, 10, 11, 12, 17, 18, 22, 31
Liquid containing 4 – 17% gentamicin sulphate 6.5B, 6.9B 10, 11
Flammable liquid containing 0.1 – 0.3% gentian violet and 2.5 – 4.5% oxytetracycline hydrochloride 3.1B, 6.1D, 6.4A, 6.8B, 6.9A, 9.1B, 9.3C 1, 2, 4, 11, 12, 18, 22
Aerosol containing 0.4 – 0.8% gentian violet and 3 – 7% oxytetracycline hydrochloride (Substance A) 6.4A, 9.1A 4, 7, 11, 12, 17, 18, 22
Aerosol containing 0.4 – 0.8% gentian violet and 3 – 7% oxytetracycline hydrochloride (Substance B) 6.3B, 6.4A, 9.1A 4, 7, 11, 12, 17, 18, 22
Gel containing 35 – 65 g/kg glycol salicylate, 0.1 – 1 g/kg heparin and 1 – 10 g/kg racementhol 3.1C, 6.3B, 6.4A 2, 11
Liquid containing 0.1 – 0.3 g/litre glycopyrrolate 6.5B, 9.2D 10, 11, 12
Solid containing gonadotrophin (Substance A) 6.8B 5, 6, 11
Solid containing gonadotrophin (Substance B) 6.3B, 6.4A, 6.5B, 6.8B 5, 6, 10, 11, 31
Solid containing 50 – 90% griseofulvin 6.5B, 6.6B, 6.7B, 6.8A 4, 5, 6, 10, 11, 31
Liquid containing 8 – 12% guaiphenesin 6.4A, 6.9B 11
Liquid containing 95 – 100% halothane 6.4A, 6.5A, 6.8A, 6.9B 4, 10, 11
Liquid containing 0.3 – 0.7% hexetidine (Substance A) 6.1D, 6.3A, 8.3A, 9.1D, 9.3C 11, 12, 34
Liquid containing 0.3 – 0.7% hexetidine (Substance B) 6.1E, 6.3A, 8.3A, 9.1B 11, 12, 34
Liquid containing 0.3 – 0.7% hydantoin 6.3A, 6.5B, 8.3A, 9.1B 10, 11, 12
Paste containing 1 – 1.3% hydantoin 6.3B, 6.4A, 6.5B, 6.6B, 9.1C 10, 11, 12
Cream containing 0.3 – 0.7% hydrocortisone, 0.3 – 0.7% lignocaine and 0.3 – 0.7% neomycin sulphate 6.5B, 6.7B, 6.8B, 9.1C 10, 11, 12, 18, 22
Liquid containing 20 – 30% hydroxyprogesterone caproate 6.1E, 6.5B, 6.7B, 6.8B, 9.1D, 9.2D 10, 11, 12, 18
Liquid containing 80 – 120 g/litre hydroxyprogesterone caproate 6.5B, 6.7B, 6.8B, 9.2D 10, 11, 12, 18
Liquid containing 0.001 – 0.007% hyoscine hydrobromide, 8 – 12% kaolin, 1 – 2% neomycin sulphate, 0.4 – 1% pectin, 1 – 3% sulphadiazine, 1 – 3% sulphaguanidine and 1 – 3% sulphamethazine 6.3B, 6.5B, 6.8B, 6.9B, 9.1D 10, 11, 12, 18
Flammable liquid containing 80 – 120 g/litre imidacloprid 3.1D, 6.1D, 6.4A, 6.9B, 9.1A, 9.2B, 9.3B, 9.4A 4, 7, 13, 17, 19, 23
Liquid containing 0.5 – 2.3% available iodine 6.3A, 6.4A, 6.5B, 6.9B, 9.1C 10, 11, 12, 34
Cream containing 1.5 – 2.5 g/kg iodine 6.3B, 6.4A, 6.5B, 9.1C 10, 11, 12, 34
Liquid containing 2.3 – 2.7% iodine 6.3A, 6.4A, 6.5B, 6.9B, 9.1A 4, 7, 10, 11, 12, 17, 34
Flammable liquid containing 2.3 – 2.7% iodine 3.1B, 6.3A, 6.4A, 6.5B, 6.9B, 9.1B 1, 2, 10, 11, 12, 34
Liquid containing 40 – 60 g/litre surfactant complexed iodine and 15 – 25 g/litre povidone iodine 6.3B, 6.5B, 6.9B, 9.1C 10, 11, 12, 34
Liquid containing 490 – 590 g/litre isoeugenol 6.1E, 6.3A, 6.4A, 6.5B, 6.9B 10, 11
Liquid containing 1 – 5 g/litre isoflupredone acetate 6.5B 10, 11
Liquid containing 95 – 100% isoflurane 6.3A, 6.4A, 6.9B 11
Liquid containing 0.1 – 0.15% ivermectin 6.5B, 6.8C, 9.1A, 9.2C, 9.4A 4, 7, 10, 13, 17
Liquid containing 0.2 – 0.3% ivermectin 6.1E, 6.5B, 6.8C, 9.1A, 9.2C, 9.4A 4, 7, 10, 13, 17
Liquid containing 0.35 – 0.5% ivermectin 6.1E, 6.8C, 9.1A, 9.2C, 9.4A 4, 7, 13, 17
Liquid containing 0.5 – 0.9 g/litre ivermectin (Substance A) 6.4A, 6.5B, 6.8A, 9.1A, 9.2C, 9.4A 4, 7, 10, 13, 17
Liquid containing 0.5 – 0.9 g/litre ivermectin (Substance B) 6.5B, 9.1A, 9.2C, 9.4A 4, 7, 10, 13, 17
Paste containing 1.4 – 2.4% ivermectin 6.1D, 6.8C, 6.9B, 9.1A, 9.2C, 9.3C, 9.4A 4, 7, 13, 17
Solid containing 1.6 – 2.4% ivermectin 6.1D, 6.8C, 6.9B, 9.1A, 9.2C, 9.3C, 9.4A 4, 5, 6, 7, 13, 17
Flammable liquid containing 3.5 – 7 g/litre ivermectin (Substance A) 3.1B, 6.1D, 6.3B, 6.4A, 6.8C, 9.1A, 9.2C, 9.3C, 9.4A 1, 2, 4, 7, 13, 17
Flammable liquid containing 3.5 – 7 g/litre ivermectin (Substance B) 3.1B, 6.1D, 6.3B, 6.4A, 6.5B, 6.8C, 9.1A, 9.2C, 9.3C, 9.4A 1, 2, 4, 7, 10, 13, 17
Solid containing 3.9 – 4.4% ivermectin 6.1C, 6.8C, 6.9B, 9.1A, 9.2B, 9.3B, 9.4A 4, 5, 6, 8, 13, 17
Liquid containing 10 – 13 g/litre ivermectin (Substance A) 6.1D, 6.8B, 6.8C, 6.9B, 9.1A, 9.2C, 9.3C, 9.4A 4, 7, 13, 17
Liquid containing 10 – 13 g/litre ivermectin (Substance B) 6.1D, 6.4A, 6.5B, 6.8C, 6.9B, 9.1A, 9.2B, 9.3C, 9.4A 4, 7, 10, 13, 17
Liquid containing 13 – 19 g/litre ivermectin 6.1D, 6.8C, 6.9B, 9.1A, 9.2C, 9.3C, 9.4A 4, 7, 13, 17
Solid containing 20 – 23% ivermectin 6.1C, 6.3B, 6.8C, 6.9A, 9.1A, 9.2B, 9.3B, 9.4A 4, 5, 6, 8, 13, 17, 31
Liquid containing 60 – 90 g/litre ivermectin 6.1C, 6.5B, 6.8C, 6.9B, 9.1A, 9.2B, 9.3B, 9.4A 4, 8, 10, 13, 17
Gel containing 5 – 9 g/kg ivermectin and 70 – 130 g/kg praziquantel 6.1D, 6.4A, 6.5B, 6.8C, 9.1A, 9.2C, 9.3C, 9.4A 4, 7, 10, 13, 17
Paste containing 14 – 22 g/litre ivermectin and 120 – 160 g/litre praziquantel 6.1D, 6.4A, 6.5B, 6.8B, 6.8C, 6.9B, 9.1A, 9.2C, 9.3C, 9.4A 4, 7, 10, 13, 17
Liquid containing 0.07 – 0.09% ivermectin and 0.08 – 0.13% sodium selenate 6.5B, 9.1A, 9.2C, 9.4A 4, 7, 10, 13, 17
Liquid containing 10 – 15% kaolin, 0.1 – 0.3% potassium chloride, 0.3 – 0.7% sodium chloride, 2 – 4% sulphadiazine and 0.3 – 0.7% trimethoprim 6.3B, 6.5B, 9.1B 10, 11, 12, 18, 22
Solid containing 60 – 90% kaolin and 10 – 30% sulphamethazine 6.8B 5, 6, 11
Liquid containing 10 – 13% ketamine hydrochloride 6.1E, 6.3B, 6.4A, 6.8B, 6.9B 11
Liquid containing 3 – 7% ketamine hydrochloride and 13 – 17% xylazine 6.1D, 6.3A, 6.4A, 6.5B, 6.6B, 6.7B, 6.8B, 6.9B, 9.1D, 9.3C 10, 11, 12, 18
Solid containing 3 – 9% ketoprofen 6.1D, 6.3B, 9.3C 5, 6, 11, 12, 18, 31
Liquid containing 10 – 12% ketoprofen 6.1D, 6.3A, 6.4A, 9.3C 11, 12, 18
Solid containing 150 – 180 g/kg lasalocid sodium 6.1D, 9.1D, 9.3C 11, 12
Liquid containing 180 – 220 g/litre lasalocid sodium 6.1D, 9.1D, 9.3C 11, 12
Flammable liquid containing 170 – 230 g/litre levamisole 3.1D, 6.1D, 6.3B, 6.4A, 6.5B, 6.6B, 6.9A, 9.3C 4, 10
Liquid containing 4 – 6% levamisole hydrochloride (Substance A) 6.1E, 6.5B, 6.6B, 6.9B 10
Liquid containing 4 – 6% levamisole hydrochloride (Substance B) 6.1E, 6.4A, 6.5B, 6.6B, 6.9B 10
Liquid containing 30 – 40 g/litre levamisole hydrochloride 6.5B, 6.6B, 6.9B 10
Liquid containing 200 – 300 g/litre levamisole hydrochloride 6.1D, 6.5B, 6.6B, 6.9A, 9.3C 4, 10, 13
Liquid containing 400 – 450 g/litre levamisole hydrochloride 6.1D, 6.5B, 6.6B, 6.9A, 9.3B 4, 10, 13
Liquid containing 3.3 – 5% levamisole hydrochloride, 0.4 – 0.8% copper carbonate and 0.02 – 0.08% sodium selenate 6.1E, 6.4A, 6.5B, 6.6B, 6.9B, 9.1B 10, 13
Liquid containing 3.3 – 5% levamisole hydrochloride, 1 – 2% copper edetate and0.06 – 0.18% sodium selenate 6.1E, 6.5B, 6.6B, 6.9B, 9.1C 10, 13
Liquid containing 33 – 50 g/litre levamisole hydrochloride, 1 – 2.4 g/litre copper sulphate and 0.6 – 1.8 g/litre sodium selenate 6.1E, 6.5B, 6.6B, 6.9B, 9.1B 10, 13
Liquid containing 33 – 50 g/litre levamisole hydrochloride, 10 – 15 g/litre copper sulphate and 0.6 – 1.8 g/litre sodium selenate 6.1E, 6.3B, 6.5B, 6.6B, 6.9B, 9.1A 4, 7, 10, 13, 17
Solid containing 30 – 42 g/kg levamisole hydrochloride and 65 – 80 g/kg niclosamide 6.1D, 6.4A, 6.5B, 6.6B, 6.9B, 9.1A, 9.3B 4, 5, 6, 7, 10, 13, 17, 19, 23, 31
Liquid containing 65 – 95 g/litre levamisole hydrochloride and 30 – 60 g/litre oxfendazole 6.1E, 6.4A, 6.5B, 6.6B, 6.8B, 6.9B, 9.1B 10, 13
Liquid containing 80 – 95 g/litre levamisole hydrochloride, 30 – 60 g/litre oxfendazole and 2.4 g/litre sodium selenate 6.1D, 6.4A, 6.5B, 6.6B, 6.8B, 6.9B, 9.1B, 9.3C 10, 13
Liquid containing 30 – 50 g/litre levamisole hydrochloride and 65 – 90 g/litre oxyclozanide 6.1E, 6.5B, 6.6B, 6.8B, 6.9B, 8.3A 10
Liquid containing 35 – 50 g/litre levamisole hydrochloride and 17 – 25 g/litre praziquantel 6.1E, 6.5B, 6.6B, 6.9B 10
Liquid containing 30 – 50 g/litre levamisole hydrochloride, 16 – 23 g/litre praziquantel, 0.3 – 0.7 g/litre copper edetate and 0.6 – 1.8 g/litre sodium selenate 6.1E, 6.5B, 6.6B, 6.9B 10
Liquid containing 31 – 50 g/litre levamisole hydrochloride, 16 – 23 g/litre praziquantel, 6.5 – 10 g/litre copper sulphate and 0.7 – 1.8 g/litre sodium selenate 6.1E, 6.3B, 6.5B, 6.6B, 6.9B, 9.1A, 9.2C 4, 7, 10, 13, 17
Liquid containing 30 – 50 g/litre levamisole hydrochloride, 15 – 23 g/litre praziquantel and 16 – 24 g/litre ricobendazole 6.1E, 6.5B, 6.6B, 6.8A, 6.9B 4, 10
Liquid containing 30 – 50 g/litre levamisole hydrochloride, 15 – 23 g/litre praziquantel, 16 – 24 g/litre ricobendazole and 0.5 – 1.5 g/litre sodium selenate 6.1E, 6.5B, 6.6B, 6.8A, 6.9B 4, 10
Liquid containing 33 – 50 g/litre levamisole hydrochloride and 16 – 24 g/litre ricobendazole 6.1E, 6.5B, 6.6B, 6.8A, 6.9B 4, 10
Liquid containing 30 – 50 g/litre levamisole hydrochloride, 16 – 24 g/litre ricobendazole and 0.5 – 1.5 g/litre sodium selenate 6.1E, 6.5B, 6.6B, 6.8A, 6.9B 4, 10
Liquid containing 3.3 – 5% levamisole hydrochloride and 0.07 – 0.18% sodium selenate 6.1E, 6.4A, 6.5B, 6.6B, 6.9B 10
Liquid containing 70 – 90 g/litre levamisole hydrochloride and 3 – 5 g/litre sodium selenate 6.1D, 6.3B, 6.4A, 6.5B, 6.6B, 6.9B, 9.1A, 9.2C, 9.3C 4, 7, 10, 13, 17
Liquid containing 1.5 – 2.5% lignocaine 6.3B, 6.6B, 6.7B, 6.9B 11
Liquid containing 1 – 8% lincomycin hydrochloride and 1 – 8% neomycin sulphate 6.5B, 6.9B 10, 11
Solid containing 10 – 30% lincomycin hydrochloride and 28 – 48% spectinomycin sulphate 6.1E, 6.4A 5, 6, 11, 31
Flammable liquid containing 20 – 40 g/litre linseed oil, 120 – 160 g/litre sulphur and 700 – 800 g/litre turpentine 3.1C, 6.1D, 6.3A, 6.4A, 6.5B, 9.1C 2, 10, 12, 18, 22
Liquid containing 50 – 110 g/litre lufenuron 6.5B, 6.9B, 9.1B 10, 13, 19, 23
Solid containing 270 – 330 g/kg lufenuron 6.5B, 6.9B, 9.1A 4, 5, 6, 7, 10, 13, 17, 19, 23, 31
Solid containing 10 – 15 g/kg maduramicin 6.3B, 6.4A, 6.5B, 6.9B 10, 11
Solid containing 2.6 – 4.6% maldison 6.8B, 6.9B, 9.1A, 9.4A 4, 5, 6, 7, 13, 17, 19, 23
Liquid containing 1 – 8% marbofloxacin 6.3B, 6.9B 11
Solid containing 1 – 8% marbofloxacin 6.9B 5, 6, 11
Liquid containing 10 – 20% marbofloxacin 6.3B, 6.4A, 6.9B 11
Liquid containing Marek’s disease virus (attenuated) 6.3B, 6.4A, 9.3C 11, 12, 18
Liquid containing Marek’s disease virus (attenuated) and turkey herpes virus (attenuated) 9.3C 12, 18
Liquid containing 3 – 7% mebendazole 6.6B, 6.8B, 6.9B
Liquid containing 0.5 – 1.5 g/litre medetomidine hydrochloride 6.9B 11
Liquid containing 2 – 6% medroxyprogesterone acetate 6.7B, 6.8B 11
Solid containing 1.4 – 5% megestrol acetate 6.7B, 6.8B 5, 6, 11
Implant containing 850 – 950 g/kg melatonin 6.1D, 6.8A, 9.3C 4, 5, 6, 11, 12, 18, 33
Liquid containing 1 – 5 g/litre meloxicam 6.8B 11
Flammable liquid containing 5.5 – 9 g/litre meloxicam 3.1C, 6.4A, 6.8B, 9.1D 2, 11, 12, 18
Flammable liquid containing 16 – 30 g/litre meloxicam 3.1C, 6.1E, 6.4A, 6.8B, 6.9B, 9.1D 2, 11, 12, 18
Liquid containing 1.5 – 2.5% mepivacaine hydrochloride 6.9B 11
Liquid containing 4.1 – 7% mepyramine maleate 6.1E 11
Liquid containing 3.5 – 4.5% methandriol dipropionate and 2.5 – 4% nandrolone decanoate 6.5B, 6.7B, 6.8A, 6.9B, 9.2D 4, 10, 11, 12, 18
Liquid containing 0.01 – 0.04% methscopolamine bromide and 1 – 5% neomycin sulphate 6.5B, 6.9B 10, 11
Liquid containing 1 – 9% methylprednisolone acetate 6.8B, 6.9B 11
Solid containing 14 – 24% metronidazole and 20 – 34% spiramycin 6.5B, 6.6A, 6.7B, 9.1A 4, 5, 6, 7, 10, 11, 12, 17, 18, 22, 31
Solid containing 20 – 30% metronidazole and 39 – 50% spiramycin 6.1E, 6.5B, 6.6A, 6.7B, 9.1A 4, 5, 6, 7, 10, 11, 12, 17, 18, 22, 31
Cream containing 0.5 – 5% miconazole 6.8B, 9.1D 11, 12, 18
Liquid containing 1 – 3% miconazole, 0.01 – 0.1% polymyxin and 0.3 – 0.7% prednisolone acetate 6.8B 11
Solid containing 1.7 – 2.4% milbemycin and 18 – 24% praziquantel 6.1E, 6.9B, 9.1A, 9.2C, 9.4B 4, 5, 6, 7, 13, 17, 19, 23
Solid containing 2.6 – 3.9% milbemycin and 6 – 10% praziquantel 6.9B, 9.1A, 9.2B, 9.4A 4, 5, 6, 7, 13, 17, 19, 23
Liquid containing 30 – 35 g/litre monensin sodium 6.1C, 6.3B, 6.5B, 8.3A, 9.1C, 9.2D, 9.3B 4, 8, 11, 12, 17, 30
Liquid containing 50 – 70 g/litre monensin sodium 6.1B, 6.5B, 8.3A, 9.1D, 9.2D, 9.3A 4, 8, 11, 12, 16, 17, 29
Solid containing 100 – 250 g/kg monensin sodium 6.1B, 6.3B, 6.5B, 8.3A, 9.1D, 9.2D, 9.3A 4, 8, 11, 12, 16, 17, 28
Capsule containing 400 – 500 g/kg monensin sodium 6.1A, 6.3B, 6.5B, 8.3A, 9.1A, 9.2B, 9.3A 4, 5, 6, 8, 11, 12, 15, 17, 27, 31
Solid containing 850 – 950 g/kg monensin sodium 6.1A, 6.3A, 6.5B, 8.3A, 9.1A, 9.2B, 9.3A 4, 9, 11, 12, 14, 26
Solid containing 25 – 40 g/kg morantel citrate 6.1E, 6.4A, 6.9B, 9.1A, 9.4C 4, 5, 6, 7, 13, 17, 31
Liquid containing 1 – 2 g/litre moxidectin (Substance A) 6.5B, 6.8B, 6.8C, 9.1A, 9.2C, 9.4C 4, 7, 10, 13, 17
Liquid containing 1 – 2 g/litre moxidectin (Substance B) 6.5B, 6.8B, 6.8C, 9.1A, 9.4C 4, 7, 10, 13, 17
Liquid containing 1 – 1.3% moxidectin 6.1E, 6.5B, 6.8B, 6.8C, 6.9B, 9.1A, 9.2C, 9.4B 4, 7, 10, 13, 17
Liquid containing 1.6 – 2% moxidectin 6.1D, 6.5B, 6.8B, 6.8C, 6.9B, 9.1A, 9.2C, 9.3C, 9.4B 4, 7, 10, 13, 17
Liquid containing 2.6 – 6 g/litre moxidectin (Substance A) 6.5B, 6.8B, 6.8C, 9.1A, 9.2C, 9.4B 4, 7, 10, 13, 17
Liquid containing 2.6 – 6 g/litre moxidectin (Substance B) 6.3B, 6.8B, 6.8C, 9.1A, 9.2C, 9.4B 4, 7, 13, 17
Liquid containing 1 – 1.5 g/litre moxidectin and 16 – 22 g/litre praziquantel 6.5B, 6.8B, 6.8C, 9.1A, 9.2C, 9.4C 4, 7, 10, 13, 17
Liquid containing 1 – 1.5 g/litre moxidectin and 1 – 1.5 g/litre sodium selenate 6.5B, 6.8B, 6.8C, 9.1A, 9.2C, 9.4C 4, 7, 10, 13, 17
Liquid containing 1.4 – 2.4 g/litre moxidectin and 2 – 2.6 g/litre sodium selenate 6.5B, 6.8B, 6.8C, 9.1A, 9.2C, 9.4C 4, 7, 10, 13, 17
Liquid containing 2 – 6% nandrolone ester 6.4A, 6.5B, 6.7B, 6.8A, 6.9B, 9.1D, 9.2D 10, 11, 12, 18
Solid containing 100 – 150 g/kg narasin 6.1B, 6.5A, 6.5B, 6.9A, 8.2C, 8.3A, 9.1B, 9.2D, 9.3A 4, 8, 11, 12, 16, 17, 28
Solid containing 75 – 95 g/kg narasin and 75 – 95 g/kg nicarbazin 6.1B, 6.9B, 8.3A, 9.1B, 9.2D, 9.3A 4, 8, 11, 12, 16, 17, 28
Solid containing 8 – 12% natamycin 6.1E, 6.3B, 8.3A 5, 6, 11, 12, 31
Solid containing 20 – 90% neomycin sulphate 6.5A, 6.5B, 6.9A 4, 10, 11
Cream containing 0.3 – 0.7% neomycin sulphate, 0.1 – 0.2% nitrofurazone and 0.1 – 0.3% prednisolone 6.3B, 6.5B, 6.7B, 6.8B, 9.1C 10, 11, 12, 18, 22
Cream containing 2 – 6 g/litre neomycin sulphate, 10 – 30 g/litre nystatin, 2 – 4 g/litre thiostrepton and 0.5 – 1.5 g/litre triamcinolone acetonide 6.5B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Cream containing 1 – 3% neomycin sulphate, 0.8 – 1.5% oleandomycin, 1 – 2.2% oxytetracycline hydrochloride and 0.02 – 0.08% prednisolone 6.5B, 6.9B, 9.1B 10, 11, 12, 18, 22
Aerosol containing 1 – 5% neomycin sulphate and 6 – 14% penicillin g procaine 6.5A, 6.5B, 6.9B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 10 – 14% neomycin sulphate and 10 – 30% penicillin g procaine 6.5B, 6.9A, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Cream containing 0.3 – 0.7% neomycin sulphate, 0.05 – 0.15% polymyxin and 0.6 – 1% zinc bacitracin 6.5B 10, 11
Liquid containing 0.3 – 0.7% neomycin sulphate and 0.1 – 0.3% prednisolone acetate 6.5B, 6.8B 10, 11
Liquid containing 3 – 7 g/litre neomycin sulphate, 0.4 – 1.4 g/litre prednisolone, 3 – 7 g/litre sulphur and 26 – 50 g/litre zinc oxide 6.5B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 0.1 – 0.3% neomycin sulphate, 0.3 – 0.9% streptomycin, 1 – 4% sulphadiazine, 1 – 3% sulphaguanidine and 1 – 3% sulphamethazine 6.3B, 6.5B, 6.8A, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Flammable liquid containing 0.3 – 0.7% neomycin undecylenate, 0.8 – 2% piperonyl butoxide, 0.1 – 0.24% pyrethrins and 0.05 – 0.15% triamcinolone acetonide 3.1B, 6.4A, 6.5B, 9.1B, 9.4C 1, 2, 10, 11, 12, 18, 22
Paste containing 16 – 20% niclosamide and 2 – 4% pyrantel pamoate 6.3B, 6.4A, 6.5B, 6.9B, 9.1A, 9.3C 4, 7, 10, 11, 12, 17, 19, 23
Paste containing 26 – 29% niclosamide and 8 – 12% pyrantel pamoate 6.4A, 6.5B, 6.9B, 9.1A, 9.3B 4, 7, 10, 11, 12, 17, 19, 23
Solid containing 20 – 30% nimesulide 6.1D, 9.3C 5, 6, 11, 12, 18
Cream containing 0.1 – 0.8% nitrofurazone 6.5B, 6.7B, 6.8B 10, 11
Liquid containing 2 – 4% N-octyl bicycloheptene dicarboxamide, 1.3 – 1.8% piperonyl butoxide and 0.7 – 1.3% pyrethrins 6.3A, 6.4A, 6.5A, 6.5B, 6.8A, 6.9B, 9.1A, 9.4B 4, 7, 10, 13, 17, 19, 23
Liquid containing 7 – 13 g/litre N-octyl bicycloheptene dicarboximide, 0.5 – 1.5 g/litre permethrin, 1 – 7 g/litre pyrethrins and 0.03 – 0.08 g/litre pyriproxyfen 6.5A, 6.5B, 9.1A, 9.4B 4, 7, 10, 13, 17, 19, 23
Liquid containing 250 – 350 g/litre nonylphenol ethoxylate 6.3B, 6.4A, 9.1B 13
Liquid containing 75 – 100% nonylphenol ethoxylate 6.1E, 6.3B, 6.4A, 9.1B 13
Liquid containing 7 – 11% nonylphenol ethoxylate iodine 6.3A, 6.4A, 6.5B, 6.9B, 9.1C 10, 13
Implant containing 3.4 – 8% oestradiol 6.7A, 6.8A, 6.9B 4, 5, 6, 7, 11, 32
Liquid containing 0.01 – 0.03% oestradiol benzoate 6.8A 4, 11
Liquid containing 0.06 – 0.08% oestradiol benzoate 6.5B, 6.8A 4, 10, 11
Liquid containing 0.1 – 0.6% oestradiol benzoate 6.4A, 6.5B, 6.7A, 6.8A, 9.1D, 9.2D 4, 7, 10, 11, 12, 18
Solid containing 2 – 2.5% oestradiol benzoate 6.7A, 6.8A, 6.9B 4, 5, 6, 7, 11
Implant containing 6 – 9% oestradiol benzoate and 65 – 80% progesterone 6.7A, 6.8A, 6.9B 4, 5, 6, 7, 11, 32
Implant containing 6 – 9% oestradiol benzoate and 65 – 80% testosterone propionate 6.7A, 6.8A, 6.9B, 9.1D 4, 5, 6, 7, 11, 12, 18, 32
Implant containing 8 – 13% oestradiol benzoate and 60 – 80% trenbolone acetate 6.1D, 6.7A, 6.8A, 6.9B, 9.3C 4, 5, 6, 7, 11, 12, 18, 33
Implant containing 7 – 13% oestradiol and 60 – 75% trenbolone acetate 6.1D, 6.7A, 6.8A, 6.9B, 9.3C 4, 5, 6, 7, 11, 12, 18, 33
Solid containing 0.7 – 1.3% oestriol 6.8A 4, 5, 6, 11
Liquid containing 3 – 5% oleandomycin phosphate and 5 – 7% oxytetracycline hydrochloride 9.1B 12, 18, 22
Solid containing 4 – 9% orbifloxacin 6.9B 5, 6, 11
Solid containing 8 – 70% oxantel pamoate, 0.5 – 7% praziquantel and 2 – 20% pyrantel pamoate 6.9B 5, 6
Solid containing 60 – 80% oxantel pamoate and 15 – 23% pyrantel pamoate 6.9B 5, 6
Liquid containing 1.5 – 2.4% oxfendazole (Substance A) 6.3B, 6.8B, 6.9B, 9.1C 13
Liquid containing 1.5 – 2.4% oxfendazole (Substance B) 6.5B, 6.8B, 6.9B, 9.1C 10, 13
Liquid containing 1.5 – 2.4% oxfendazole (Substance C) 6.8B, 6.9B, 9.1C 13
Liquid containing 3 – 24% oxfendazole (Substance A) 6.5B, 6.8B, 6.9B, 9.1B 10, 13
Liquid containing 3 – 24% oxfendazole (Substance B) 6.8B, 6.9B, 9.1B 13
Paste containing 15 – 23% oxfendazole 6.8B, 6.9B, 9.1B 13
Liquid containing 70 – 110 g/litre oxfendazole 6.3B, 6.8B, 6.9B, 9.1B 13
Liquid containing 1.8 – 2.5% oxfendazole, 1 – 2% cobalt edetate and 0.06 – 0.18% sodium selenate 6.1D, 6.5B, 6.6A, 6.7B, 6.8B, 6.9B, 9.1B, 9.3C 4, 10, 13
Liquid containing 3 – 6% oxfendazole, 0.2 – 0.3% cobalt edetate and 0.18 – 0.32% sodium selenate 6.5B, 6.8B, 6.9B, 9.1B, 9.2C 10, 13
Liquid containing 3 – 6% oxfendazole, 0.7 – 1% cobalt edetate and 0.18 – 0.32% sodium selenate 6.3B, 6.4A, 6.5B, 6.7B, 6.8B, 6.9B, 9.1B, 9.2C 10, 13
Liquid containing 7 – 11% oxfendazole, 0.1 – 0.3% cobalt edetate and 0.3 – 0.6% sodium selenate 6.1D, 6.5B, 6.6A, 6.8B, 6.9B, 9.1B, 9.2C, 9.3C 4, 10, 13
Liquid containing 7 – 11% oxfendazole, 0.35 – 0.6% cobalt edetate and 0.35 – 0.48% sodium selenate 6.3B, 6.5B, 6.7B, 6.8B, 6.9B, 9.1B, 9.2C 10, 13
Liquid containing 7 – 11% oxfendazole, 0.45 – 0.7% cobalt edetate and 0.47 – 0.6% sodium selenate 6.1E, 6.3B, 6.4A, 6.5B, 6.7B, 6.8B, 6.9B, 9.1B, 9.2C 10, 13
Liquid containing 18 – 23 g/litre oxfendazole, 0.5 – 2 g/litre cobalt edetate and 0.6 – 1.8 g/litre sodium selenate (Substance A) 6.3B, 6.5B, 6.8B, 6.9B, 9.1C 10, 13
Liquid containing 18 – 23 g/litre oxfendazole, 0.5 – 2 g/litre cobalt edetate and 0.6 – 1.8 g/litre sodium selenate (Substance B) 6.8B, 6.9B, 9.1C 13
Liquid containing 22.5 – 25 g/litre oxfendazole 3 – 5 g/litre cobalt edetate and 1.1 – 1.8 g/litre sodium selenate 6.3B, 6.4A, 6.5B, 6.8B, 6.9B, 9.1B, 9.2C 10, 13
Liquid containing 7 – 11% oxfendazole and 0.48 – 0.6% sodium selenate 6.1E, 6.3A, 6.4A, 6.8B, 6.9B, 9.1B, 9.2C 13
Flammable liquid containing 10 – 24% oxytetracycline dihydrate 3.1B, 6.1D, 6.5B, 6.8B, 6.9A, 8.2C, 8.3A, 9.1B, 9.3C 1, 2, 4, 10, 11, 12, 18, 22
Liquid containing 10 – 24% oxytetracycline dihydrate (Substance A) 6.1D, 6.4A, 6.8A, 6.9B, 9.1B 4, 11, 12, 18, 22
Liquid containing 10 – 24% oxytetracycline dihydrate (Substance B) 6.1D, 6.3B, 6.8A, 6.9B, 8.3A, 9.1B, 9.3B 4, 11, 12, 18, 22
Liquid containing 10 – 24% oxytetracycline dihydrate (Substance C) 6.3A, 6.4A, 6.5B, 6.8A, 6.9B, 9.1B 4, 10, 11, 12, 18, 22
Liquid containing 10 – 24% oxytetracycline dihydrate (Substance D) 6.9B, 9.1B 11, 12, 18, 22
Liquid containing 10 – 24% oxytetracycline dihydrate (Substance E) 6.4A, 6.8A, 6.9B, 9.1B 4, 11, 12, 18, 22
Liquid containing 10 – 24% oxytetracycline dihydrate (Substance F) 6.8B, 6.9B, 9.1B 11, 12, 18, 22
Liquid containing 26 – 38% oxytetracycline dihydrate 6.1D, 6.4A, 6.8A, 6.9B, 9.1A 4, 7, 11, 12, 17, 18, 22
Solid containing 0.8 – 2.4% oxytetracycline hydrochloride 9.1C 12, 18, 22
Flammable aerosol containing 2.6 – 10% oxytetracycline hydrochloride 2.1.2A, 6.1D, 6.3B, 6.4A, 6.8B, 6.9A, 9.1B 1, 4, 11, 12, 18, 22
Aerosol containing 2.6 – 10% oxytetracycline hydrochloride 9.1B 12, 18, 22
Solid containing 2.6 – 7% oxytetracycline hydrochloride 6.3A, 6.4A, 9.1B 5, 6, 11, 12, 18, 22, 31
Solid containing 8 – 20.6% oxytetracycline hydrochloride (Substance A) 6.3B, 9.1B 5, 6, 11, 12, 18, 22, 31
Solid containing 8 – 20.6% oxytetracycline hydrochloride (Substance B) 9.1B 12, 18, 22
Liquid containing 8 – 23% oxytetracycline hydrochloride (Substance A) 6.5B, 9.1B 10, 11, 12, 18, 22
Liquid containing 8 – 23% oxytetracycline hydrochloride (Substance B) 6.3B, 9.1B 11, 12, 18, 22
Liquid containing 8 – 23% oxytetracycline hydrochloride (Substance C) 6.3A, 6.4A, 6.5B, 6.8B, 6.9B, 9.1B 10, 11, 12, 18, 22
Liquid containing 8 – 23% oxytetracycline hydrochloride (Substance D) 6.3A, 6.4A, 6.5B, 6.8A, 6.9B, 9.1B 4, 10, 11, 12, 18, 22
Solid containing 26 – 46% oxytetracycline hydrochloride 9.1A 4, 7, 12, 17, 18, 22
Solid containing 8 – 24% oxytetracycline quaternary ammonium complex 6.3B, 6.4A, 9.1A 4, 7, 11, 12, 17
Liquid containing 9 – 23 IU/ml oxytocin 6.8A 4, 11
Liquid containing 800 – 900 g/litre paraffin oil 6.1E, 6.3B
Liquid containing Pasteurella haemolytica (inactivated) 6.3B, 6.5B, 6.7B, 6.8A, 6.8C 4, 10, 11
Solid containing 50 – 98% penethamate hydriodide 6.1E, 6.5B, 9.1A 4, 5, 6, 7, 10, 11, 12, 17, 18, 22, 31
Liquid containing 10 – 20% penicillin benethamine and 10 – 20% penicillin g procaine 6.5B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 10 – 20% penicillin g benzathine and 10 – 20% penicillin g procaine 6.5B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 12 – 20% penicillin g benzathine, 1 – 5% penicillin g potassium and 14 – 22% penicillin g procaine 6.3B, 6.5B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 3 – 9% penicillin g potassium and 20 – 30% penicillin g procaine 6.3B, 6.5B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 5 – 24% penicillin g procaine 6.5B, 9.1B 10, 11, 12, 18, 22
Liquid containing 26 – 60% penicillin g procaine 6.5B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 26 – 54% pentobarbitone sodium 6.1C, 6.4A, 6.8B, 6.9A, 9.1C, 9.3B 4, 7, 11, 12, 17, 18, 22
Liquid containing 15 – 18.5% pentobarbitone sodium and 2 – 3% sodium phenytoin 6.1D, 6.4A, 6.5B, 6.7B, 6.8A, 6.9A, 9.3B 4, 10, 11, 12, 18, 22
Liquid containing 0.3 – 0.7% permethrin 6.3B, 6.4A, 6.5A, 6.5B, 6.9B, 9.1A, 9.4B 4, 7, 10, 13, 17
Solid containing 1 – 2.2% permethrin 6.5A, 6.5B, 6.9B, 9.1A, 9.4B 4, 7, 10, 13, 17, 19, 23
Liquid containing 10 – 12 g/litre permethrin 6.1E, 6.3B, 6.4A, 6.5A, 6.5B, 6.9B, 9.1A, 9.4B 4, 7, 10, 13, 17
Flammable liquid containing 30 – 50 g/litre permethrin 3.1D, 6.1D, 6.3B, 6.4A, 6.5A, 6.5B, 6.9B, 9.1A, 9.4A 4, 7, 10, 13, 17, 19, 23
Liquid containing 10 – 13 g/litre permethrin and0.2 – 0.8 g/litre pyriproxyfen 6.1D, 6.5A, 6.5B, 6.9B, 8.2C, 8.3A, 9.1A, 9.2D, 9.3C, 9.4A 4, 7, 10, 13, 17
Liquid containing 360 – 430 g/litre permethrin and 1.5 – 4.5 g/litre pyriproxyfen 6.1D, 6.3B, 6.4A, 6.5A, 6.5B, 6.9B, 9.1A, 9.3C, 9.4A 4, 7, 10, 13, 17, 19, 23
Liquid containing 3.5 – 7% pethidine hydrochloride 6.1E, 6.9B 11
Solid containing 18 – 24% phenobarbitone 6.1D, 6.5B, 6.7B, 6.8B, 6.9B, 9.3C 5, 6, 10, 11, 12, 18, 31
Liquid containing 20 – 25% phenylbutazone 6.1D, 6.4A, 9.3C 11, 12, 18
Solid containing 60 – 75% phenylbutazone 6.1D, 6.4A, 6.5A, 6.5B, 9.3B 10, 11, 12, 18, 22
Paste containing 120 – 200 g/kg phenylbutazone 6.1D, 6.4A, 9.3C 11, 12, 18
Liquid containing 150 – 200 g/litre phenylbutazone 6.1D, 6.3A, 8.3A, 9.3C 11, 12, 18
Solid containing 350 – 450 g/kg phenylbutazone 6.1D, 6.4A, 9.3C 5, 6, 11, 12, 18, 31
Solid containing 680 – 780 g/kg phenylbutazone 6.1D, 6.4A, 9.3B 5, 6, 11, 12, 18, 22, 31
Liquid containing 45 – 55 g/litre phenylpropanolamine hydrochloride 6.9B 11
Solid containing 1 – 4% pimobendan 6.3B, 6.9B, 8.3A 5, 6, 11, 31
Liquid containing 0.7 – 1.3% piperonyl butoxide and 0.1 – 0.3% pyrethrins 6.1D, 6.3B, 6.4A, 6.5A, 6.5B, 6.6A, 6.7A, 6.8A, 6.9A, 9.1A, 9.2D, 9.3C, 9.4C 4, 9, 10, 13, 17
Liquid containing 1 – 1.7% piperonyl butoxide and 0.12 – 0.36% pyrethrins 6.1E, 6.3B, 6.5A, 6.5B, 8.3A, 9.1A, 9.4B 4, 7, 10, 13, 17
Liquid containing 0.3 – 0.7% pirlimycin hydrochloride 9.1D 12, 18
Liquid containing 90 – 100% polyalkylene oxide derivative of a synthetic alcohol 6.1D, 6.3B, 6.4A, 9.1A, 9.3C 4, 7, 13, 17
Liquid containing 0.05 – 0.07% polyandroalbumin 6.5B 10, 11
Liquid containing 5 – 30% polysulfated glycosaminoglycan 6.9B 11
Solid containing 80 – 90% porcine somatotrophin 6.5B, 6.8B, 6.9B 5, 6, 10, 11, 31
Solid containing 35 – 45% potassium bromide 6.1D, 6.3A, 6.4A, 6.5B, 6.9B, 9.1C, 9.2C, 9.3C 5, 6, 10, 11, 12, 18, 22, 31
Flammable aerosol containing 10 – 15% povidone iodine 2.1.2A, 6.3A, 6.4A, 6.5B, 9.1C 1, 10, 11, 12, 34
Flammable liquid containing 40 – 50 g/litre povidone iodine 3.1B, 6.3B, 6.4A, 6.5B, 9.1C 1, 2, 10, 11, 12, 34
Liquid containing 50 – 175 g/litre povidone iodine 6.3A, 6.4A, 6.5B, 9.1C 10, 11, 12, 34
Gel containing 90 – 110 g/kg povidone iodine 6.3A, 6.4A, 6.5B, 9.1C 10, 11, 12, 34
Solid containing 25 – 45% praziquantel 6.1E 5
Flammable liquid containing 36 – 44 g/litre praziquantel 3.1D, 6.1E, 6.3A, 6.4A, 6.8A, 9.1D 4, 13, 19
Paste containing 18 – 32 g/litre praziquantel and 250 – 350 g/litre pyrantel pamoate 6.9B
Solid containing 50 – 70 g/kg praziquantel and 640 – 720 g/kg pyrantel pamoate 6.9B 5, 6
Solid containing 4.5 – 5.5% prednisolone 6.8B, 6.9B 5, 6, 11
Liquid containing 10 – 40 g/litre prednisolone sodium succinate 6.3A, 6.4A, 6.8B 11
Liquid containing 2 – 3% progesterone 6.5B, 6.7B, 6.8B, 9.1D, 9.2D 10, 11, 12, 18
Implant containing 4.5 – 5.5% progesterone 6.5B, 6.7B, 6.8B 5, 6, 10, 11, 31, 33
Implant containing 6 – 12% progesterone 6.7B, 6.8B 5, 6, 11, 32
Liquid containing 8 – 12% proligestone 6.7B, 6.8B 11
Solid containing 950 – 1000 g/kg propantheline bromide 6.1D, 6.5B, 6.8B, 9.1B, 9.3B 5, 6, 10, 11, 12, 31
Solid containing 300 – 700 g/kg propentofylline 6.1D, 6.9B, 9.3C 5, 6, 11, 12, 18
Flammable liquid containing 100 – 120 g/litre propetamphos 3.1C, 6.1D, 6.3B, 6.4A, 6.8A, 6.9A, 9.1A, 9.3B, 9.4B 2, 4, 7, 13, 17
Liquid containing 12.8 – 18.5% propetamphos 6.1D, 6.3A, 6.4A, 6.9A, 9.1A, 9.3B, 9.4B 4, 7, 13, 17
Liquid containing 36 – 44% propetamphos 6.1C, 6.9A, 9.1A, 9.3B, 9.4A 4, 9, 13
Liquid containing 1 – 1.3% propofol 6.9B 11
Collar containing 7.5 – 9.8% propoxur 9.1A, 9.2C 7, 12, 17, 18, 22
Liquid containing 11 – 15% prostianol 6.8A, 6.9A 4, 11
Liquid containing 10 – 20 g/litre pyrantel pamoate 6.9B
Solid containing 50 – 90% pyrantel pamoate 6.9B 5, 6
Flammable liquid containing 14 – 24 g/litre pyriproxyfen 3.1D, 6.1E, 6.4A, 9.1B 13, 19, 23
Flammable liquid containing 80 – 120 g/litre pyriproxyfen 3.1D, 6.1E, 6.4A, 6.5B, 9.1A 4, 7, 10, 13, 17, 19, 23
Liquid containing 0.025 – 0.075% reserpine 6.9B 11
Liquid containing 14 – 26 g/litre ricobendazole 6.5B, 6.6B, 6.8A, 6.9B 4, 10
Liquid containing 14 – 26 g/litre ricobendazole, 0.5 – 1.5 g/litre cobalt edetate and 0.5 – 1.5 g/litre sodium selenate 6.5B, 6.6B, 6.8A, 6.9B 4, 10
Solid containing 50 – 80 g/kg robenidine hydrochloride 9.1A 4, 7, 12, 17
Liquid containing 0.05 – 0.15% romifidine 6.9B 11
Solid containing 12 – 16.8% rotenone and 3.5 – 6.5% sulphur 6.1C, 6.3A, 6.4A, 6.9A, 9.1A, 9.3B 4, 5, 6, 8, 13, 17, 31
Solid containing 950 – 1000 g/kg roxarsone 6.1C, 6.9B, 9.1B, 9.3B 4, 7, 11, 12, 17
Solid containing 10 – 20% salinomycin sodium 6.1C, 6.3A, 6.9B, 8.3A, 9.3B 4, 8, 11, 12, 17
Solid containing 60 – 120 g/kg salinomycin sodium 6.1C, 6.3A, 6.9B, 8.3A, 9.1C, 9.2D, 9.3B 4, 8, 11, 12, 17
Flammable liquid containing 50 – 150 g/litre selamectin 3.1B, 6.1E, 6.3B, 6.4A, 6.8B, 6.9B, 9.1A, 9.2B, 9.4A 1, 2, 4, 7, 13, 17, 19, 23
Solid containing 0.006 – 0.016% selenium and compounds 6.8B 5, 6, 11
Solid containing 10 – 15% selenium and compounds 6.1B, 6.6B, 6.9A, 9.1B, 9.3A 4, 5, 6, 7, 11, 12, 17, 20, 24
Solid containing 5 – 8% semduramicin sodium 6.1C, 6.9B, 9.3B 4, 8, 11, 12, 17
Solid containing 450 – 550 g/kg sodium dichloroisocyanurate 6.1D, 6.3A, 6.4A, 9.1A, 9.2A, 9.3C 4, 5, 6, 7, 11, 12, 17, 31, 34
Liquid containing 0.2 – 0.49% sodium selenate 9.1C 12, 20, 24
Liquid containing 0.5 – 0.98% sodium selenate 6.1E, 9.1C, 9.2C 11, 12, 20, 24
Liquid containing 1 – 1.24% sodium selenate (Substance A) 6.1D, 6.6B, 6.9B, 9.1C, 9.2C 11, 12, 20, 24
Liquid containing 1 – 1.24% sodium selenate (Substance B) 6.1D, 6.4A, 6.5B, 6.6B, 6.9B, 9.1C, 9.2C 10, 11, 12, 20, 24
Liquid containing 1 – 1.24% sodium selenate (Substance C) 6.1D, 6.3B, 6.4A, 6.6B, 6.9B, 9.1C, 9.3C 11, 12, 20, 24
Liquid containing 1.25 – 1.9% sodium selenate 6.1D, 6.6B, 6.9B, 9.1C, 9.2C, 9.3C 11, 12, 20, 24
Solid containing 0.03 – 0.09% sodium selenite 6.1E 5, 11
Liquid containing 0.045 – 0.075% sodium selenite 6.1E 11
Liquid containing 0.5 – 0.7% sodium selenite 6.1D, 6.4A, 6.5B, 9.1C, 9.3B 10, 11, 12, 20, 24
Liquid containing 1 – 3% sodium selenite 6.1C, 6.5B, 6.6B, 6.9B, 9.1C, 9.3B 7, 10, 11, 12, 17, 20, 24
Liquid containing 25 – 35 g/litre spinosad 6.9B, 9.1B, 9.4A 4, 7, 13, 17
Liquid containing 4 – 6% stanozolol 6.7B, 6.8A, 6.9B 4, 11
Solid containing 3 – 7% streptomycin, 23 – 25% sulphadiazine, 20 – 40% sulphamerazine and 20 – 40% sulphapyridine 6.1E, 6.3A, 6.4A, 6.5B, 6.6B, 6.9B, 9.1A 4, 5, 6, 7, 10, 11, 12, 17, 18, 22, 31
Liquid containing 10 – 25% sulphadiazine and 1 – 7% trimethoprim 6.1E, 6.3A, 6.5B, 6.8A, 6.9B, 8.3A, 9.1B 4, 10, 11, 12, 18, 22
Liquid containing 37 – 47% sulphadiazine and 6 – 10% trimethoprim 6.1E, 6.3A, 6.4A, 6.5B, 6.9B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Solid containing 50 – 60% sulphadiazine and 8 – 14% trimethoprim 6.1E, 6.3A, 6.4A, 6.5B, 6.9B, 9.1A 4, 5, 6, 7, 10, 11, 12, 17, 18, 22, 31
Solid containing 63 – 73% sulphadiazine and 12 – 20% trimethoprim 6.1D, 6.3A, 6.4A, 6.5B, 6.9B, 9.1A, 9.3C 4, 5, 6, 7, 10, 11, 12, 17, 18, 22, 31
Solid containing 17 – 25% sulphadimethoxine sodium and 2 – 6% trimethoprim 6.3A, 6.4A, 6.5B, 6.9B, 9.1A 4, 5, 6, 7, 10, 11, 12, 17, 18, 22, 31
Solid containing 95 – 100% sulphamethazine 6.8B 5, 6, 11
Solid containing 6 – 14% sulphamethazine and 1 – 10% tiamulin hydrogen fumarate 6.8B, 6.9B, 9.1A 4, 5, 6, 7, 11, 12, 17, 18, 22
Liquid containing 16 – 24% sulphamethazine and 2 – 6% trimethoprim 6.8B, 6.9B, 8.2C, 8.3A 11
Solid containing 38 – 48% sulphamethazine and 4 – 12% trimethoprim 6.8B, 6.9B 11
Solid containing 6 – 14% sulphamethazine and 10 – 20% tylosin 6.4A, 6.5B, 6.8B, 9.1A 4, 7, 10, 11, 12, 17
Solid containing 30 – 50% sulphamethoxypyridazine and 4 – 12% trimethoprim 6.1E, 6.5B, 6.9B 5, 6, 10, 11, 31
Liquid containing 14 – 22% sulphisoxazole and 1 – 5% trimethoprim 6.3A, 6.4A, 6.5B, 6.9B 10, 11
Flammable liquid containing 10 – 13% temephos 3.1C, 6.1E, 6.3B, 6.4A, 6.9A, 9.1A, 9.3B, 9.4B 2, 4, 7, 13, 17
Solid containing 16 – 30 g/kg temephos 6.9B, 9.1A, 9.3C, 9.4C 4, 5, 6, 7, 13, 17
Liquid containing 200 – 210 g/litre temephos 6.1E, 6.3B, 6.4A, 6.9A, 9.1A, 9.3B, 9.4B 4, 7, 13, 17
Liquid containing 300 – 400 g/litre temephos 6.1D, 6.3B, 6.4A, 6.5B, 6.9A, 9.1A, 9.3A, 9.4A 4, 7, 10, 13, 17
Solid containing 750 – 900 g/kg tepoxalin 6.3A, 6.9B 5, 6, 11, 31
Liquid containing 67 – 73% tergitol NP-9 6.1E, 8.3A, 9.1B 13
Liquid containing 0.7 – 1.3% testosterone ester 6.5B, 6.7B, 6.8A, 6.9B, 9.1D, 9.2D 4, 10, 11, 12, 18
Solid containing 10 – 20% tetracycline hydrochloride 6.3A, 6.4A, 6.8B, 6.8C, 6.9B, 9.1A 4, 5, 6, 7, 11, 12, 17, 18, 22, 31
Solid containing 90 – 95% thiopentone sodium 6.1C, 6.3B, 6.9B, 9.1C, 9.3B 4, 7, 11, 12, 17, 18, 22, 31
Solid containing 96 – 100% thiopentone sodium 6.1C, 6.9B, 9.1C, 9.3B 4, 7, 11, 12, 17, 18, 22
Solid containing 225 – 275 g/kg thiophanate 6.5B, 9.1B 5, 6, 10, 13, 31
Solid containing 1 – 10% tiamulin hydrogen fumarate 6.9B, 9.1A 4, 7, 11, 12, 17
Liquid containing 3 – 7% tiletamine hydrochloride and 3 – 7% zolazepam hydrochloride 6.9B 11
Solid containing 15 – 30% tiletamine hydrochloride and 15 – 30% zolazepam hydrochloride 6.9B 5, 6, 11
Solid containing 16 – 24% tilmicosin 6.1E, 6.4A, 6.9B, 9.1D 11, 12
Liquid containing 26 – 39% tilmicosin 6.1E, 6.4A, 6.9B, 9.1A 4, 7, 11, 12, 17, 18, 22
Liquid containing 80 – 150 g/litre tolazoline hydrochloride 6.1E, 6.9B 11
Flammable liquid containing 2 – 7% tolfenamic acid 3.1D, 6.1E, 6.3A, 6.4A, 6.5B, 6.8B, 6.9B 10, 11
Solid containing 7.5 – 11% tolfenamic acid 6.1E, 6.9B 5, 6, 11
Solid containing 11.5 – 20% tolfenamic acid 6.1D, 6.9B, 9.3C 5, 6, 11, 12, 18
Liquid containing 20 – 30 g/litre toltrazuril 6.3B, 6.4A, 6.8B, 6.9B, 9.2D 11, 12
Liquid containing 45 – 55 g/litre toltrazuril 6.8B, 6.9B 11
Solid containing 950 – 990 g/kg trichlorfon 6.1C, 6.4A, 6.5B, 6.6B, 6.8B, 6.9A, 9.1A, 9.2B, 9.3A, 9.4C 4, 5, 6, 8, 10, 13, 17, 31
Liquid containing 80 – 100 g/litre triclabendazole 6.1E, 6.5B, 6.9B 10
Liquid containing 200 – 280 g/litre triclabendazole 6.1D, 6.5B, 6.9B, 9.3C 10, 13
Flammable liquid containing 25 – 30 g/litre triflumuron 3.1D, 6.3A, 6.4A, 6.8A, 6.9B, 9.1B, 9.4B 4, 13
Liquid containing 10 – 25% tylosin (Substance A) 6.4A, 6.5B, 9.1A 4, 7, 10, 11, 12, 17, 18, 22
Liquid containing 10 – 25% tylosin (Substance B) 6.4A, 6.5B, 9.1A, 9.2D 4, 7, 10, 11, 12, 17, 18, 22
Solid containing 26 – 60% tylosin 6.4A, 6.5B, 9.1A 4, 5, 6, 7, 10, 11, 12, 17, 18, 22, 31
Solid containing 10 – 95% tylosin 6.4A, 6.5A, 6.5B, 9.1A, 7, 10, 11, 12, 17, 18, 22
Solid containing 42 – 70% virginiamycin 6.1E 11
Liquid containing 1 – 2.4% xylazine 6.3B, 6.6B, 6.7B, 6.9B 11
Liquid containing 3 – 6% xylazine 6.1E, 6.3B, 6.6B, 6.7B, 6.9B 11
Liquid containing 10 – 15% xylazine 6.1D, 6.3A, 6.4A, 6.6B, 6.7B, 6.9B, 9.3C 11, 12, 18
Liquid containing 0.8 – 1.5% yohimbine hydrochloride 6.1E, 6.9B 11
Solid containing 10 – 20% zinc bacitracin 6.5B, 9.1A 4, 7, 10, 11, 12, 17
Solid containing 75 – 100% zinc oxide 9.1A, 9.3C 4, 7, 13, 17, 21, 25
Solid containing 95 – 100% zinc sulphate 6.1D, 6.3B, 6.9B, 8.3A, 9.1A, 9.3C 4, 5, 6, 7, 13, 17, 21, 25, 31




Table 2
Veterinary medicines that are manufactured for exportation
Substance Hazard classification(s) Variation Code(s)
Liquid containing 1.5 – 3% albendazole (Substance A) 6.5B, 6.6B, 6.8A, 6.9B 11
Solid containing 2 – 4% albendazole 6.5B, 6.6B, 6.8A, 6.9B 11
Liquid containing 10 – 20% albendazole 6.1E, 6.5B, 6.6B, 6.8A, 6.9B 11
Cream containing 0.3 – 0.7% cetrimide and 0.3 – 0.7% chlorhexidine gluconate 6.3B, 6.5B, 6.8B, 9.1B 11, 12
Liquid containing 5 – 6.5% chlorhexidine gluconate (Substance A) 6.3B, 6.4A, 9.1A 7, 11, 12, 17
Liquid containing 5 – 6.5% chlorhexidine gluconate (Substance B) 6.3B, 6.4A, 6.8B, 6.9B, 9.1A 7, 11, 12, 17
Flammable liquid containing 2.5 – 3% chlorpyrifos 3.1C, 6.1D, 6.3A, 6.8B, 6.9B, 8.3A, 9.1A, 9.2C, 9.3B, 9.4A 7, 11, 12, 17
Flammable liquid containing 0.26 – 5% diazinon 3.1C, 6.1D, 6.3A, 6.6B, 6.8B, 8.3A, 9.1A, 9.3B, 9.4B 7, 11, 12, 17
Liquid containing 2.7 – 3.5% iodine (Substance A) 6.3A, 6.5B, 6.9B, 8.3A, 9.1B 11, 12
Liquid containing 2.7 – 3.5% iodine (Substance B) 6.5B, 6.9B, 8.2C, 8.3A, 9.1B 11, 12
Liquid containing 1 – 3.8% levamisole hydrochloride 6.5B, 6.6B, 6.9B 11
Liquid containing 4 – 9% levamisole hydrochloride 6.1E, 6.5B, 6.6B, 6.9B 11
Liquid containing 0.04 – 0.075% propetamphos 6.1E, 6.3A, 6.4A, 9.1B 11, 12
Flammable liquid containing 30 – 44% propetamphos 3.1D, 6.1C, 6.3B, 6.4A, 6.9A, 9.1A, 9.3B, 9.4A 7, 11, 12, 17
Liquid containing 0.8 – 2.4% sodium selenite 6.1C, 6.5B, 6.6B, 6.9B, 9.1C, 9.3B 7, 11, 12, 17






Schedule 2
Changes to controls for veterinary medicines
Control – Hazardous Substances (Classes 1 to 5 Controls) Regulations 2001 Changes to Controls
New regulation 56A The regulations apply to each hazardous substance described in
Table 1 of Schedule 1 with variation code 1 as if the following regulation were inserted immediately after regulation 56:
56A Exception to approved handler requirement for transportation of packaged veterinary medicines
(1) Regulation 56 is deemed to be complied with if—
(a) in the case of a hazardous substance being transported on land—
(i) in the case of a substance being transported by rail, the person who drives the rail vehicle that is transporting the substance is fully trained in accordance with the approved safety system for the time being approved under section 6D of the Transport Services Licensing Act 1989; and
(ii) in every other case, the person who drives, loads, and unloads the vehicle that is transporting the substance has a current dangerous goods endorsement on his or her driver licence; and
(iii) in all cases, Land Transport Rule 45001/1: Dangerous Goods 2005 (made under the Land Transport Act 1998) is complied with; or
(b) in the case of a hazardous substance being transported by sea, one of the following is complied with:
(i) Maritime Rule 24A: Carriage of Cargoes – Dangerous Goods (made under Part 3 of the Maritime Transport Act 1994):
(ii) International Maritime Dangerous Goods Code; or
(c) in the case of a hazardous substance being transported by air, Civil Aviation Rule 92: Carriage of Dangerous Goods (made under Part 3 of the Civil Aviation Act 1990) is complied with.

(2) Subclause (1)(a)—
(a) does not apply to a tank wagon or a transportable container to which the Hazardous Substances (Tank Wagons and Transportable Containers) Regulations 2004 applies; but
(b) despite paragraph (a), does apply to an intermediate bulk container that complies with chapter 6.5 of the UN Model Regulations.
(3) Subclause (1)(c)—
(a) applies to pilots, aircrew, and airline ground personnel loading and managing hazardous substances within an aerodrome; but
(b) does not apply to the handling of a hazardous substance in any place that is not within an aerodrome.
New regulation 56B The regulations apply to each hazardous substance described in
Table 1 of Schedule 1 with variation code 1 as if the following regulation were inserted immediately after regulation 56A:
56B Exception to approved handler requirement for veterinarians
(1) Regulation 56 is deemed to be complied with by a veterinarian who is storing or who has under his or her control a hazardous substance for use in the ordinary course of his or her business or employment as a veterinarian, if that veterinarian is the holder of a current annual retention certificate.
(2) Despite subclause (1), regulation 56B does not apply to a veterinarian who is storing a hazardous substance for the purposes of resale.
Regulation 81 This regulation does not apply to a person in charge of a hazardous substance location if—
(a) the hazardous substance location is situated on a farm of not less than 4 hectares; and
(b) the combined quantity of each class 3.1B or class 3.1C hazardous substance described in Table 1 of Schedule 1 with variation code 2 and any petrol, aviation gasoline, racing gasoline, or any other class 3.1B or 3.1C hazardous substance stored at the location is less than 2,000 litres; and

(c) either—
(i) the following requirements are complied with:
(A) each substance is stored in 1 or more secure containers, each of which has a capacity of less than 250 litres; and
(B) each container complies with regulation 11 and Schedule 2 of the Hazardous Substances (Packaging) Regulations 2001; and
(C) each container is—
(1) situated not less than 15 metres from any area of high intensity land use or area of regular habitation; and
(2) situated either in the open or in a well-ventilated building; and
(3) in a compound or located so that any spillage of the substance will not endanger any building, or flow into any stream, lake, or natural water; or
(ii) the following requirements are complied with:
(A) each substance is stored in an above ground stationary tank that complies with the Stationary Container Controls in Schedule 8 of the Hazardous Substances (Dangerous Goods and Scheduled Toxic Substances) Transfer Notice 2004 as amended by this Schedule; and
(B) each of the above ground stationary tanks is situated—
(1) not less than 20 metres from any area of high-intensity land use or area of regular habitation; and
(2) 6 metres from any combustible materials; and
(3) in a compound or located so that any spillage of the substance will not endanger any building, or flow into any stream, lake, or natural water.
New regulation 89A The regulations apply to each hazardous substance described in
Table 1 of Schedule 1 with variation code 3 as if the following regulation were inserted immediately after regulation 89:

89A Exception to approved handler requirement for transportation of packaged veterinary medicines
(1) Regulation 89 is deemed to be complied with if—
(a) in the case of a hazardous substance being transported on land—
(i) in the case of a hazardous substance being transported by rail, the person who drives the rail vehicle that is transporting the substance is fully trained in accordance with the approved safety system for the time being approved under section 6D of the Transport Services Licensing Act 1989; and
(ii) in every other case, the person who drives, loads, and unloads the vehicle that is transporting the substance has a current dangerous goods endorsement on his or her driver licence; and
(iii) in all cases, Land Transport Rule 45001/1: Dangerous Goods 2005 (made under the Land Transport Act 1998) is complied with; or
(b) in the case of a hazardous substance being transported by sea, one of the following is complied with:
(i) Maritime Rule 24A: Carriage of Cargoes – Dangerous Goods (made under Part 3 of the Maritime Transport Act 1994):
(ii) International Maritime Dangerous Goods Code; or
(c) in the case of a hazardous substance being transported by air, Civil Aviation Rule 92: Carriage of Dangerous Goods (made under Part 3 of the Civil Aviation Act 1990) is complied with.
(2) Subclause (1)(a)—
(a) does not apply to a tank wagon or a transportable container to which the Hazardous Substances (Tank Wagons and Transportable Containers) Regulations 2004 applies; but
(b) despite paragraph (a), does apply to an intermediate bulk container that complies with chapter 6.5 of the UN Model Regulations.

(3) Subclause (1)(c)—
(a) applies to pilots, aircrew, and airline ground personnel loading and managing hazardous substances within an aerodrome; but
(b) does not apply to the handling of a hazardous substance in any place that is not within an aerodrome.
New regulation 89B The regulations apply to each hazardous substance described in
Table 1 of Schedule 1 with variation code 3 as if the following regulation were inserted immediately after regulation 89A:
89B Exception to approved handler requirement for veterinarians
(1) Regulation 89 is deemed to be complied with by a veterinarian who is storing or who has under his or her control a hazardous substance for use in the ordinary course of his or her business or employment as a veterinarian, if that veterinarian is the holder of a current annual retention certificate.
(2) Despite subclause (1), regulation 89B does not apply to a veterinarian who is storing a hazardous substance for the purposes of resale.
Control – Hazardous Substances (Classes 6, 8, and 9 Controls) Regulations 2001 Changes to Controls
Regulation 5 The regulations apply to each hazardous substance described in
Table 1 of Schedule 1 with variation code 4 as if regulation 5 were omitted.
Regulation 7 (1) The regulations apply to each hazardous substance described in Table 1 of Schedule 1 with variation code 5, when the substance is being dispensed or administered to an animal, as if regulation 7 were omitted.
(2) Subclause (1) does not apply to a substance that is—
(a) a powder, granule or other finally divided material; or
(b) dissolved prior to administration to an animal.
Regulation 8 (1) The regulations apply to each hazardous substance described in Table 1 of Schedule 1 with variation code 6, when the substance is being dispensed or administered to an animal, as if regulation 8 were omitted.

(2) Subclause (1) does not apply to a substance that is—
(a) a powder, granule or other finally divided material; or
(b) dissolved prior to administration to an animal.
Regulation 9 The regulations apply to each hazardous substance described in Schedule 1 with variation code 7 as if regulation 9 were omitted.
This regulation applies to each hazardous substance described in Schedule 1 with variation code 8 as if the regulation were omitted and the following substituted:
This substance, in any quantity, must be secured while not in use so that a person who should not have access to this substance cannot access the substance.
New regulation 9A The regulations apply to each hazardous substance described in
Table 1 of Schedule 1 with variation code 9 as if the following regulation were inserted immediately after regulation 9:
9A Exception to approved handler requirement for transportation of packaged veterinary medicines
(1) Regulation 9 is deemed to be complied with if—
(a) in the case of a hazardous substance being transported on land—
(i) in the case of a substance being transported by rail, the person who drives the rail vehicle that is transporting the substance is fully trained in accordance with the approved safety system for the time being approved under section 6D of the Transport Services Licensing Act 1989; and
(ii) in every other case, the person who drives, loads, and unloads the vehicle that is transporting the substance has a current dangerous goods endorsement on his or her driver licence; and
(iii) in all cases, Land Transport Rule 45001/1: Dangerous Goods 2005 (made under the Land Transport Act 1998) is complied with; or
(b) in the case of a hazardous substance being transported by sea, one of the following is complied with:
(i) Maritime Rule 24A: Carriage of Cargoes – Dangerous Goods (made under Part 3 of the Maritime Transport Act 1994):
(ii) International Maritime Dangerous Goods Code; or
(c) in the case of a hazardous substance being transported by air, Civil Aviation Rule 92: Carriage of Dangerous Goods (made under Part 3 of the Civil Aviation Act 1990) is complied with.
(2) Subclause (1)(a)—
(a) does not apply to a tank wagon or a transportable container to which the Hazardous Substances (Tank Wagons and Transportable Containers) Regulations 2004 applies; but
(b) despite paragraph (a), does apply to an intermediate bulk container that complies with chapter 6.5 of the UN Model Regulations.
(3) Subclause (1)(c)—
(a) applies to pilots, aircrew, and airline ground personnel loading and managing hazardous substances within an aerodrome; but
(b) does not apply to the handling of a hazardous substance in any place that is not within an aerodrome.
New regulation 9B The regulations apply to each hazardous substance described in
Table 1 of Schedule 1 with variation code 9 as if the following regulation were inserted immediately after regulation 9A:
9B Exception to approved handler requirement for veterinarians
(1) Regulation 9 is deemed to be complied with by a veterinarian who is storing or who has under his or her control a hazardous substance for use in the ordinary course of his or her business or employment as a veterinarian, if that veterinarian is the holder of a current annual retention certificate.
(2) Despite subclause (1), regulation 9B does not apply to a veterinarian who is storing a hazardous substance for the purposes of resale.
Regulation 10 The regulations apply to each hazardous substance described in
Table 1 of Schedule 1 with variation code 10, as if each item in Schedule 2 of the regulations relating to these hazard classifications were omitted and the following substituted:
HazardClassification Liquid (L) Solid (kg)
6.5A 1 3
6.5B 1 3
Regulation 11 The regulations apply to each hazardous substance described in Schedule 1 with variation code 11 as if regulation 11 were omitted.
Regulations 32 and 33 The regulations apply to each hazardous substance described in Schedule 1 with variation code 12 as if regulations 32 and 33 were omitted.
Regulation 32 This regulation applies to each hazardous substance described in Schedule 1 with variation code 13 as if subclauses (1) and (2) were omitted.
Control – Hazardous Substances (Packaging) Regulations 2001 Changes to Controls
Regulation 19 This regulation applies to each hazardous substance described in Table 1 of Schedule 1 with variation code 14 as if the words “Schedule 1” in subclause (1)(a) were omitted and the following substituted:
Schedule 2
This regulation applies to each hazardous substance described in Table 1 of Schedule 1 with variation code 15 as if the words “Schedule 1” in subclause (1)(a) were omitted and the following substituted:
Schedule 3
This regulation applies to each hazardous substance described in Table 1 of Schedule 1 with variation code 16 as if the words “Schedule 2” in subclause (1)(b) were omitted and the following substituted:
Schedule 3
Control – Hazardous Substances (Tracking) Regulations 2001 Changes to Controls
Regulations 4 to 6 The regulations apply to each hazardous substance described in Schedule 1 with variation code 17 as if regulations 4 to 6 were omitted.

Control – Hazardous Substances (Disposal) Regulations 2001 Changes to Controls
Regulations 11 The regulations apply to export-only substances as if regulation 11 were omitted.
Control – Hazardous Substances (Emergency Management) Regulations 2001 Changes to Controls
Regulations 6 to 8 The regulations apply to export-only substances as if regulations 6 to 8 were omitted.
Regulation 8 This regulation applies to each hazardous substance described in Table 1 of Schedule 1 with variation code 18 as if subclause (f) were omitted.
This regulation applies to each hazardous substance described in Table 1 of Schedule 1 with variation code 19 as if the following subclause were inserted immediately after subclause (f):
(fa) Subclause (f) shall only apply if the amount of the substance contained in a package is greater than or equal to 100 ml (liquid) or 100 g (solid or paste).
This regulation applies to each hazardous substance described in Table 1 of Schedule 1 with variation code 20 as if the following subclause were inserted immediately after subclause (f):
(fa) Subclause (f) shall only apply if the amount of the substance contained in a package is greater than or equal to 500 ml.
This regulation applies to each hazardous substance described in Table 1 of Schedule 1 with variation code 21 as if the following subclause were inserted immediately after subclause (f):
(fa) Subclause (f) shall only apply if the amount of the substance contained in a package is greater than or equal to 5 kg.
Regulation 36 This regulation applies to each hazardous substance described in Schedule 1 as if the following subclauses were inserted immediately after subclause (3):
(4) For the purposes of this regulation, and regulations 37 to 40, any hazardous substance contained in pipework that is installed and operated so as to manage any loss of containment in the pipework—
(a) is not to be taken into account in determining whether a place is required to have a secondary containment system; and
(b) is not required to be located in a secondary containment system.
(5) In this clause, pipework—
(a) means piping that—
(i) is connected to a stationary container; and
(ii) is used to transfer a hazardous substance into or out of the stationary container; and
(b) includes a process pipeline or a transfer line.
Control – Hazardous Substances (Identification) Regulations 2001 Changes to Controls
Regulations 6 to 9, 11, 13, 14, 18, 19 (a) – (e), 20, 22, 24, 25 (a) – (d) The regulations apply to export-only substances, when contained within the inner packaging of a multiple package, as if regulations 6 to 9, 11, 13, 14, 18, 19 (a) – (e), 20, 22, 24, and 25 (a) – (d) were omitted.
Regulation 9 The regulations apply to each hazardous substance described in
Table 1 of Schedule 1 with variation code 22 as if regulation 9 were omitted.
This regulation applies to each hazardous substance described in Table 1 of Schedule 1 with variation code 23 as if the regulation were omitted and the following substituted:
A hazardous substance must be identified by an indication that it is ecotoxic when the amount of the substance contained in a package is greater than or equal to 100 ml (liquid) or 100 g (solid or paste).
This regulation applies to each hazardous substance described in Table 1 of Schedule 1 with variation code 24 as if the regulation were omitted and the following substituted:
A hazardous substance must be identified by an indication that it is ecotoxic when the amount of the substance contained in a package is greater than or equal to 500 ml.
This regulation applies to each hazardous substance described in Table 1 of Schedule 1 with variation code 25 as if the regulation were omitted and the following substituted:
A hazardous substance must be identified by an indication that it is ecotoxic when the amount of the substance contained in a package is greater than or equal to 5 kg.
Regulations 14, 25 and 46 These regulations apply to each hazardous substance described in Table 1 of Schedule 1 with variation code 26 as if the substance is a class 6.1B hazardous substance but is not a class 6.1A hazardous substance.
These regulations apply to each hazardous substance described in Table 1 of Schedule 1 with variation code 27 as if the substance is a class 6.1C hazardous substance but is not a class 6.1A hazardous substance.
These regulations apply to each hazardous substance described in Table 1 of Schedule 1 with variation code 28 as if the substance is a class 6.1C hazardous substance but is not a class 6.1B hazardous substance.
These regulations apply to each hazardous substance described in Table 1 of Schedule 1 with variation code 29 as if the substance is a class 6.1D hazardous substance but is not a class 6.1B hazardous substance.
These regulations apply to each hazardous substance described in Table 1 of Schedule 1 with variation code 30 as if the substance is a class 6.1D hazardous substance but is not a class 6.1C hazardous substance.
Regulations 19(f), 25(e), The regulations apply to export-only substances as if regulations 19(f),
25(f), 36(8) 25(e), 25(f), and 36(8) were omitted.
Regulation 20 The regulations apply to each hazardous substance described in Table 1 of Schedule 1 with variation code 18 as if regulation 20 were omitted.
This regulation applies to each hazardous substance described in Table 1 of Schedule 1 with variation code 19 as if, after the word “substance” in the second line, the following were inserted:
, when the amount of the substance contained in a package is greater than or equal to 100 ml (liquid) or 100 g (solid or paste),
This regulation applies to each hazardous substance described in Table 1 of Schedule 1 with variation code 20 as if, after the word “substance” in the second line, the following were inserted:
, when the amount of the substance contained in a package is greater than or equal to 500 ml,
This regulation applies to each hazardous substance described in Table 1 of Schedule 1 with variation code 21 as if, after the word “substance” in the second line, the following were inserted:
, when the amount of the substance contained in a package is greater than or equal to 5 kg,
Regulation 25 (1) This regulation applies to each hazardous substance described in Table 1 of Schedule 1 with variation code 31 as if the substance were not a class 6.3, class 6.4, or class 6.5 (as the case may be) hazardous substance.
(2) Subclause (1) does not apply to a substance that is—
(a) a powder, granule or other finally divided material; or
(b) dissolved prior to administration to an animal.
The regulations apply to each hazardous substance described in Table 1 of Schedule 1 with variation code 32 as if regulation 25 were omitted.
This regulation applies to each hazardous substance described in Table 1 of Schedule 1 with variation code 33 as if the substance were not a class 6.7, class 6.8, or class 6.9 (as the case may be) hazardous substance.
Regulation 30 This regulation applies to export-only substances as if the regulation were omitted and the following substituted:
(1) This subclause applies to export-only substances in multiple packaging and single containers.
(2) The outer packaging of a multiple package or the packaging of a single package, which is not contained within a multiple package, to which subclause (1) applies, must bear:
(a) the information required by whichever of regulation 8 to 14 applies to the substance; or
(b) the labelling or marking required by—
(i) in all cases, Land Transport Rule 45001/1: Dangerous Goods 2005 (made under the Land Transport Act 1998) is complied with; or
(ii) Civil Aviation Rule 92: Carriage of Dangerous Goods (made under Part 3 of the Civil Aviation Act 1990); or
(iii) Maritime Rule 24A: Carriage of Cargoes – Dangerous Goods (made under Part 3 of the Maritime Transport Act 1994); or
(c) in the case of an ecotoxic substance, the pictogram for “Dangerous for the Environment” as described in directive 92/32/EEC; or
(d) the relevant class or subclass label assigned by the UN Model Regulations.
(3) A substance to which this regulation applies must be identified by enough information to enable its New Zealand manufacturer to be contacted, either in person or by telephone.
(4) A substance to which this regulation applies shall not have on it or its packaging, or with it, any information suggesting that it belongs to a class or subclass it does not in fact belong to.
(5) An export-only substance which complies with subclauses (1) to (4) of this regulation does not need to comply with regulations 18, 19(a) – (e), and 20 to 25(a) – (d).
Regulation 52 This regulation applies to each hazardous substance described in Table 1 of Schedule 1 with variation code 34 as if the words “at every vehicular and pedestrian access to the building, and every vehicular and pedestrian access to land where the building is located” in subclause (1) were omitted and the following substituted:
, in the case of a building where milking animals are milked, at the primary human entrance to the building, or in all other cases, at every vehicular and pedestrian access to the building
This regulation applies to each hazardous substance described in Table 1 of Schedule 1 with variation code 34, where that hazardous substance is located in a building where milking animals are milked, as if subclause (2) were omitted.
Control – Schedule 8 of the Hazardous Substances (Dangerous Goods and Scheduled Toxic Substances) Transfer Notice 2004 Changes to Controls
Clause 1 This clause applies to each hazardous substance described in Schedule 1 as if the words “Schedules 1 and 2” in subclause (1) were omitted and the following substituted:
Schedule 1 of the Hazardous Substances (Veterinary Medicines) Transfer Notice 2005.
Clause 100 This clause applies to each hazardous substance described in Schedule 1 as if subclause (1) were omitted and the following substituted:
(1) In this Part, existing stationary container system means a stationary container system to which this Schedule applies that, immediately before 1 July 2005,—
(a) was being used to contain a substance described in Schedule 1 of the Hazardous Substances (Veterinary Medicines) Transfer Notice 2005; or
(b) was designed to be used to contain a substance described in that Table, and construction of the stationary container system to that design had commenced.

Control – Schedule 10 of the Hazardous Substances (Dangerous Goods and Scheduled Toxic Substances) Transfer Notice 2004 Changes to Controls
Clause 1 This clause applies to each hazardous substance described in Schedule 1 as if the words “Schedule 1” were omitted and the following substituted:
Schedule 1 of the Hazardous Substances (Veterinary Medicines) Transfer Notice 2005.
Clause 33 This clause applies to each hazardous substance described in Schedule 1 as if the words “Subject to subclause (2)” in subclause (1) were omitted.
This clause applies to each hazardous substance described in Schedule 1 as if subclause (2) were omitted.

Schedule 3
New controls for veterinary medicines

1 Export-only substances
The substances described in Table 2 of Schedule 1 may only be manufactured for exportation and may not be offered for sale or otherwise used in New Zealand.


Schedule 4
Transitional controls
Contents

1 Purpose of Schedule2 Persons may comply with Act and controls at any time3 Schedule does not apply to new locations or new substances at existing locations4 Compliance with obligations and restrictions as at 30 June 2005 for transitional period5 Transitional provision for hazardous substance locations6 Full test certificate for hazardous substance location7 Approved handlers8 Existing stationary container systems9 Packaging10 10 Identification, documentation, and signage11 Fire extinguishers, emergency management response plans, and secondary containment

______________________________

1 Purpose of Schedule
(1) The purpose of this Schedule is to provide for a transitional period to allow persons dealing with hazardous substances to which this notice applies to comply with the Act, and controls under the Act, in relation to those hazardous substances.
(2) This Schedule achieves the purpose described in subclause (1) by—
(a) providing that, for a period of 6 months from the commencement of this notice, a person may comply with the obligations and restrictions that applied to those hazardous substances immediately before the commencement of this notice, as if this notice (other than this Schedule) had not been given; and
(b) providing for obligations and restrictions that apply after the expiry of that 6 month period to progressively impose the requirements of the Act, and controls under the Act, in relation to those hazardous substances.
2 Persons may comply with Act and controls at any time
Except as specifically provided in this Schedule, this Schedule does not prevent a person from complying with the Act, and controls under the Act, as if this Schedule did not exist.
3 Schedule does not apply to new locations or new substances at existing locations
Nothing in this Schedule applies to any of the following:
(a) a hazardous substance described in Schedule 1 that was not lawfully used immediately before 1 July 2005:
(b) a hazardous substance location that was not in use immediately before 1 July 2005:
(c) a hazardous substance at a hazardous substance location if the hazardous substance was not permitted to be stored at the location immediately before that date:
(d) a stationary container system to which Schedule 8 of the Hazardous Substances (Dangerous Goods and Scheduled Toxic Substances) Transfer Notice 2004 applies by virtue of clause 6(1)(k) of this notice.
4 Compliance with obligations and restrictions as at 30 June 2005 for transitional period
(1) A person complies with the Act in relation to a hazardous substance to which this notice applies, if the person complies with all obligations and restrictions that were in force in relation to the hazardous substance as at the close of 30 June 2005.
(2) This subclause is subject to any other provision of this Schedule.
(3) This clause expires with the close of 31 December 2005.
5 Transitional provision for hazardous substance locations
(1) This clause applies to every licence granted or deemed to be granted by the Authority under section 217 of the Act, and every provisional licence granted under section 218 of the Act, that is in force immediately before the close of 30 June 2005.
(2) Every licence to which this clause applies continues in force for the purposes of this Schedule.
(3) On and from 1 January 2006 every licence to which this clause applies is deemed to be a test certificate issued under—
(a) in the case of a class 2.1.2 or class 3.1 hazardous substance, regulation 81 of the Hazardous Substances (Classes 1 to 5 Controls) Regulations 2001; or
(b) in the case of a class 5.1.1 hazardous substance, regulation 98 of those regulations.
(4) A test certificate referred to in subclause (3) expires with the close of 30 June 2006.
(5) While a test certificate referred to in subclause (3) is in force, regulations 77(2) and 94(3) of the Hazardous Substances (Classes 1 to 5 Controls) Regulations 2001 do not apply to the hazardous substance location to which the test certificate relates.
6 Full test certificate for hazardous substance location
The holder of a test certificate referred to in clause 5(3) must obtain a test certificate issued by a test certifier no later than the close of 30 June 2006.
7 Approved handlers
(1) Where regulation 9 of the Hazardous Substances (Classes 6, 8, and 9 Controls) Regulations 2001 requires that something be done in relation to a hazardous substance to which this notice applies by an approved handler, that regulation is complied with if that thing is done by a person who establishes, that he or she, during the whole of a qualifying period referred to in subclause (2), has been handling the hazardous substance concerned or any other substance with similar hazardous properties in the relevant phase of its lifecycle under one or more of the enactments relevant to that handling referred to in regulation 6(1) of the Hazardous Substances and New Organisms (Personnel Qualifications) Regulations 2001.
(2) For the purposes of subclause (1) a qualifying period is any consecutive 2 year period commencing on or after 2 July 1999 and ending on or before the close of 1 July 2006.
(3) This clause expires with the close of 31 December 2006.
8 Existing stationary container systems
(1) In this clause, existing stationary container system means a stationary container system to which Schedule 8 of the Hazardous Substances (Dangerous Goods and Scheduled Toxic Substances) Transfer Notice 2004 applies that, immediately before the commencement of this notice,—
(a) was being used to contain a substance described in Schedule 1; or
(b) was designed to be used to contain a substance described in Schedule 1 and construction of the stationary container system to that design had commenced.
(2) An existing stationary container system is not required to comply with the provisions of Schedule 8 of the Hazardous Substances (Dangerous Goods and Scheduled Toxic Substances) Transfer Notice (except as required under this clause) if—
(a) it is used—
(i) in the case of a stationary container system to which subclause (1)(a) applies, for the purpose for which it was used immediately before the commencement of this notice; or
(ii) in the case of a stationary container system to which subclause (1)(b) applies, for the purpose for which it was designed; and
(b) the person in charge of it complies with clauses 101 to 103 of Part 20 of Schedule 8 of the Hazardous Substances (Dangerous Goods and Scheduled Toxic Substances) Transfer Notice 2004 (if required) provided that clauses 101 to 103 shall be read as if references therein to “this notice” are references to this notice.
(3) Despite subclause (2), Part 18 and Part 19 of the Hazardous Substances (Dangerous Goods and Scheduled Toxic Substances) Transfer Notice 2004 apply to any repair, alteration, or maintenance performed on an existing stationary container system the subject of this clause.
9 Packaging
(1) Packaging of a hazardous substance to which this notice applies is not required to comply with the Hazardous Substances (Packaging) Regulations 2001 if it complies with the requirements for packaging that applied to the hazardous substance at the close of 30 June 2005.
(2) This clause expires with the close of 30 June 2007.
10 Identification, documentation, and signage
(1) A person is not required to comply with the regulations specified in subclause (2) in relation to a hazardous substance to which this notice applies if the person complies with the requirement
for identification, documentation, and signage in relation to that substance that applied to the hazardous substance at the close of 30 June 2005.
(2) The regulations are—
(a) the Hazardous Substances (Identification) Regulations 2001; and
(b) regulations 11 to 14 of the Hazardous Substances (Disposal) Regulations 2001; and
(c) regulations 6 to 20 and 42 of the Hazardous Substances (Emergency Management) Regulations 2001.
(3) This clause expires with the close of 30 June 2007.
11 Fire extinguishers, emergency management response plans, and secondary containment
(1) A person in charge of a place where a hazardous substance to which this notice applies is present is not required to comply with regulations 21 to 41 of the Hazardous Substances (Emergency Management) Regulations 2001 if that person complies with the requirements for fire extinguishers, emergency management response plans and secondary containment that applied in relation to the substance at the close of 30 June 2005.
(2) This clause expires with the close of 30 June 2006.